(+)-artemisinin multiple interactions EXP 6480464 [artemisinin results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 (+)-artemisinin increases expression ISO Cyp2b10 (Mus musculus) 6480464 artemisinin results in increased expression of CYP2B10 mRNA CTD PMID:16919048 and PMID:17962186 (+)-artemisinin increases activity ISO Cyp2b10 (Mus musculus) 6480464 artemisinin results in increased activity of CYP2B10 protein CTD PMID:16919048 (+)-artemisinin increases expression EXP 6480464 artemisinin results in increased expression of CYP2B6 mRNA CTD PMID:15761118 and PMID:18332078 (+)-artemisinin affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of artemisinin CTD PMID:12920490 (+)-catechin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA CTD PMID:25663641 (+)-epicatechin-3-O-gallate multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA CTD PMID:25663641 (+)-isoborneol multiple interactions EXP 6480464 isoborneol inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 (+)-Nornicotine increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of nornicotine CTD PMID:30906561 (+)-schisandrin B multiple interactions ISO Cyp2b3 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP2B3 mRNA] CTD PMID:31150632 (-)-anisomycin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Anisomycin promotes the reaction [[1 more ... CTD PMID:23539296 (-)-anisomycin multiple interactions EXP 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:23539296 (-)-cotinine increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of Cotinine CTD PMID:12488541 (-)-epigallocatechin 3-gallate multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA CTD PMID:25663641 (-)-selegiline decreases activity EXP 6480464 Selegiline results in decreased activity of CYP2B6 protein CTD PMID:25656918 (-)-selegiline multiple interactions EXP 6480464 Selegiline inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:25656918 (-)-trans-epsilon-viniferin decreases activity EXP 6480464 epsilon-viniferin results in decreased activity of CYP2B6 protein CTD PMID:12818727 (1->4)-beta-D-glucan multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2B10 mRNA CTD PMID:36331819 (E)-roxithromycin decreases activity EXP 6480464 Roxithromycin results in decreased activity of CYP2B6 protein CTD PMID:17164692 (E,E)-germacrone increases expression EXP 6480464 germacrone results in increased expression of CYP2B6 mRNA CTD PMID:23850985 (E,E)-germacrone decreases activity EXP 6480464 germacrone results in decreased activity of CYP2B6 protein CTD PMID:23850985 (R)-camphor multiple interactions EXP 6480464 Camphor inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 (R,R,R)-alpha-tocopherol decreases expression ISO Cyp2b10 (Mus musculus) 6480464 alpha-Tocopherol results in decreased expression of CYP2B10 mRNA CTD PMID:26102010 (S)-nicotine increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Nicotine CTD PMID:12488541 (S)-nicotine affects oxidation EXP 6480464 CYP2B6 gene polymorphism affects the oxidation of Nicotine CTD PMID:30906561 (S)-nicotine increases oxidation EXP 6480464 CYP2B6 protein results in increased oxidation of Nicotine CTD PMID:30906561 (S)-nicotine multiple interactions EXP 6480464 CYP2B6 gene polymorphism affects the reaction [CYP2A6 protein results in increased metabolism of Nicotine] CTD PMID:18004205 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of 1 more ... CTD PMID:9733665 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases hydroxylation EXP 6480464 CYP2B6 protein results in increased hydroxylation of 1 more ... CTD PMID:12167570 and PMID:9047321 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o more ... CTD PMID:15548381 and PMID:21924250 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions EXP 6480464 o and p'-DDT inhibits the reaction [Androstenols inhibits the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA]] CTD PMID:10037683 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO Cyp2b10 (Mus musculus) 6480464 o and p'-DDT affects the expression of CYP2B10 mRNA CTD PMID:18925944 1,2-dichloroethane increases expression ISO Cyp2b10 (Mus musculus) 6480464 ethylene dichloride results in increased expression of CYP2B10 mRNA CTD PMID:28189721 and PMID:28960355 1,4-dichlorobenzene increases expression ISO Cyp2b10 (Mus musculus) 6480464 4-dichlorobenzene results in increased expression of CYP2B10 mRNA CTD PMID:28541575 1,4-naphthoquinone increases abundance EXP 6480464 CYP2B6 protein results in increased abundance of 1 and 4-naphthoquinone CTD PMID:16243959 1,8-cineole multiple interactions EXP 6480464 Eucalyptol inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 1-\{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl\}-1H-imidazole multiple interactions EXP 6480464 [sulconazole co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA and [sulconazole co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 1-\{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl\}-1H-imidazole increases expression EXP 6480464 sulconazole results in increased expression of CYP2B6 mRNA CTD PMID:31312845 1-naphthol increases abundance EXP 6480464 CYP2B6 protein results in increased abundance of 1-naphthol CTD PMID:16243959 1-naphthyl isothiocyanate increases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA more ... CTD PMID:20551477 and PMID:32198087 1-naphthyl isothiocyanate multiple interactions ISO Cyp2b3 (Rattus norvegicus) 6480464 ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA] more ... CTD PMID:32198087 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with NADP] results in decreased activity of CYP2B6 protein CTD PMID:11805216 and PMID:16485904 17alpha-ethynylestradiol decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of CYP2B10 mRNA CTD PMID:27818225 17alpha-ethynylestradiol increases expression ISO Cyp2b10 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of CYP2B10 mRNA CTD PMID:12948398 17alpha-ethynylestradiol affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of Ethinyl Estradiol CTD PMID:16485904 17beta-estradiol multiple interactions EXP 6480464 [Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:20079471 and PMID:21768169 17beta-estradiol multiple interactions ISO Cyp2b3 (Rattus norvegicus) 6480464 [Estradiol co-treated with Plant Preparations] results in decreased expression of CYP2B3 mRNA CTD PMID:26945725 17beta-estradiol multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Estradiol promotes the reaction [GADD45B protein binds to CYP2B10 promoter] more ... CTD PMID:23684557 17beta-estradiol increases expression ISO Cyp2b10 (Mus musculus) 6480464 Estradiol results in increased expression of CYP2B10 mRNA CTD PMID:11075820 more ... 17beta-estradiol affects expression ISO Cyp2b10 (Mus musculus) 6480464 Estradiol affects the expression of CYP2B10 mRNA CTD PMID:7771797 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CYP2B6 mRNA CTD PMID:20079471 and PMID:22837389 2,2',3,3',6,6'-hexachlorobiphenyl decreases expression ISO Cyp2b10 (Mus musculus) 6480464 2 more ... CTD PMID:28431184 2,2',3,3',6,6'-hexachlorobiphenyl increases expression ISO Cyp2b10 (Mus musculus) 6480464 2 more ... CTD PMID:28431184 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [2 more ... CTD PMID:23457121 more ... 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO Cyp2b10 (Mus musculus) 6480464 2 more ... CTD PMID:17324954 more ... 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Cyp2b10 (Mus musculus) 6480464 2 more ... CTD PMID:17324954 more ... 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP 6480464 2 more ... CTD PMID:31173147 2,2',4,4'-Tetrabromodiphenyl ether increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of 2 more ... CTD PMID:23249762 and PMID:23537005 2,2',4,4'-Tetrabromodiphenyl ether increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of 2 more ... CTD PMID:23249762 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:24218150 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 [2 more ... CTD PMID:24218150 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 2 more ... CTD PMID:17324954 more ... 2,2',4,5'-Tetrabromodiphenyl ether increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of 2 more ... CTD PMID:23249762 2,3',4,4',5-Pentachlorobiphenyl affects response to substance EXP 6480464 CYP2B6 gene SNP affects the susceptibility to 2 more ... CTD PMID:25839716 2,3',4,4',5-Pentachlorobiphenyl increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of 2 more ... CTD PMID:27208082 2,3,4,3',4'-Pentachlorobiphenyl affects response to substance EXP 6480464 CYP2B6 gene SNP affects the susceptibility to 2 more ... CTD PMID:25839716 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2B6 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cyp2b10 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2B10 mRNA CTD PMID:17627975 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cyp2b10 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CYP2B10 mRNA CTD PMID:26377647 and PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2B6 mRNA CTD PMID:23669205 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2B10 mRNA CTD PMID:19770486 and PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:25975270 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2B3 mRNA CTD PMID:19692669 and PMID:32387183 2,4,6-Triphenyl-1-hexene decreases expression ISO Cyp2b10 (Mus musculus) 6480464 2 more ... CTD PMID:18560529 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of 2 more ... CTD PMID:22738989 2,6-di-tert-butyl-4-methylphenol increases expression EXP 6480464 Butylated Hydroxytoluene results in increased expression of CYP2B6 mRNA CTD PMID:18570159 2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid increases expression EXP 6480464 Ro 21-5104 results in increased expression of CYP2B6 mRNA and Ro 21-5104 results in increased expression of CYP2B6 protein CTD PMID:25313206 2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid multiple interactions EXP 6480464 NR1I2 mRNA promotes the reaction [Ro 21-5104 results in increased expression of CYP2B6 mRNA] CTD PMID:25313206 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Verapamil results in decreased activity of CYP2B10 protein CTD PMID:18420780 2-Dechloroethylifosfamide affects chemical synthesis EXP 6480464 CYP2B6 protein affects the chemical synthesis of dechloroethylifosfamide CTD PMID:15875221 2-n-Propyl-4-pentenoic acid increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of 2-propyl-4-pentenoic acid CTD PMID:16945988 2-Naphthalenethiol increases expression EXP 6480464 2-naphthalenethiol results in increased expression of CYP2B6 mRNA CTD PMID:36356836 2-naphthol increases abundance EXP 6480464 CYP2B6 protein results in increased abundance of 2-naphthol CTD PMID:16243959 2-nitroanisole increases oxidation EXP 6480464 CYP2B6 protein results in increased oxidation of 2-nitroanisole CTD PMID:17159769 and PMID:21218109 2-nitroanisole increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of 2-nitroanisole CTD PMID:15144223 2-nitrophenol affects chemical synthesis EXP 6480464 CYP2B6 protein affects the chemical synthesis of 2-nitrophenol CTD PMID:11409192 2-nitrophenol affects chemical synthesis ISO Cyp2b3 (Rattus norvegicus) 6480464 CYP2B6 protein affects the chemical synthesis of 2-nitrophenol CTD PMID:11409192 2-nitrotoluene increases expression ISO Cyp2b10 (Mus musculus) 6480464 2-nitrotoluene results in increased expression of CYP2B10 mRNA CTD PMID:15618236 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 3 more ... CTD PMID:19692669 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO Cyp2b3 (Rattus norvegicus) 6480464 AHR gene mutant form inhibits the reaction [3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 3 more ... CTD PMID:30312631 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Cyp2b10 (Mus musculus) 6480464 3 more ... CTD PMID:30312631 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:19692669 3,3',5,5'-tetrabromobisphenol A increases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 tetrabromobisphenol A results in increased expression of CYP2B6 mRNA CTD PMID:27914987 3,5-diethoxycarbonyl-1,4-dihydrocollidine increases expression ISO Cyp2b10 (Mus musculus) 6480464 3 more ... CTD PMID:21826054 3,5-xylenol increases oxidation EXP 6480464 CYP2B6 protein results in increased oxidation of 3 and 5-xylenol analog CTD PMID:27665777 3,5-xylenol multiple interactions EXP 6480464 [CYP2B6 protein results in increased oxidation of 3 and 5-xylenol analog] which results in increased abundance of 4-(methylsulfinyl)phenol analog CTD PMID:27665777 3-chloropropane-1,2-diol decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in decreased expression of CYP2B6 mRNA CTD PMID:28522335 3-methylcholanthrene decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Methylcholanthrene results in decreased expression of CYP2B3 mRNA CTD PMID:11328961 3-methylcholanthrene decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Methylcholanthrene results in decreased expression of CYP2B10 mRNA CTD PMID:30503582 3H-1,2-dithiole-3-thione decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in decreased expression of CYP2B3 mRNA CTD PMID:19162173 4-(methylsulfinyl)phenol multiple interactions EXP 6480464 [CYP2B6 protein results in increased oxidation of 3 and 5-xylenol analog] which results in increased abundance of 4-(methylsulfinyl)phenol analog CTD PMID:27665777 4-(methylsulfinyl)phenol increases abundance EXP 6480464 CYP2B6 protein results in increased abundance of 4-(methylsulfinyl)phenol analog CTD PMID:27665777 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:12920169 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions EXP 6480464 [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:32672941 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases activity EXP 6480464 CYP2B6 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:10799646 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 more ... CTD PMID:29285606 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases abundance EXP 6480464 CYP2B6 protein results in increased abundance of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 4-Aminophenyl ether increases expression EXP 6480464 di-(4-aminophenyl)ether results in increased expression of CYP2B6 mRNA CTD PMID:36356836 4-bromo-2-chlorophenol multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol CTD PMID:23415833 4-Hydroxy-N-desmethyltamoxifen increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen CTD PMID:29285606 4-Hydroxy-N-desmethyltamoxifen multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen] which results in increased abundance of 4-hydroxy-N-desmethyltamoxifen metabolite CTD PMID:29285606 4-hydroxycyclophosphamide increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of 4-hydroxycyclophosphamide CTD PMID:24819615 4-hydroxynon-2-enal multiple interactions EXP 6480464 [CYP2B6 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid more ... CTD PMID:21766881 4-Hydroxyvalproic acid increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of 4-hydroxyvalproate CTD PMID:16945988 4-nonylphenol multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA] more ... CTD PMID:17483497 4-nonylphenol multiple interactions EXP 6480464 4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA] CTD PMID:17483497 4-nonylphenol increases expression ISO Cyp2b10 (Mus musculus) 6480464 4-nonylphenol results in increased expression of CYP2B10 mRNA CTD PMID:17483497 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of CYP2B6 mRNA CTD PMID:17483497 5-hydroxydiclofenac multiple interactions EXP 6480464 [CYP2B6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac CTD PMID:24246759 5-Hydroxyflavone increases oxidation EXP 6480464 CYP2B6 protein results in increased oxidation of 5-hydroxyflavone CTD PMID:30964977 5-Hydroxyvalproic acid increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of 5-hydroxyvalproate CTD PMID:16945988 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP2B6 mRNA CTD PMID:17954527 more ... 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases activity EXP 6480464 Omeprazole results in increased activity of CYP2B6 protein CTD PMID:19118567 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Omeprazole results in decreased activity of CYP2B10 protein CTD PMID:18420780 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Omeprazole affects the expression of CYP2B3 mRNA CTD PMID:19483382 5-methoxy-N,N-diisopropyltryptamine decreases activity EXP 6480464 5-methoxy-N and N-diisopropyltryptamine analog results in decreased activity of CYP2B6 protein CTD PMID:26599973 5-methoxy-N,N-diisopropyltryptamine multiple interactions EXP 6480464 [5-methoxy-N and N-diisopropyltryptamine analog results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion CTD PMID:26599973 5-methoxyindole decreases activity ISO Cyp2b10 (Mus musculus) 6480464 5-methoxyindole results in decreased activity of CYP2B10 protein CTD PMID:18420780 5-methyltryptamine multiple interactions EXP 6480464 [5-methyltryptamine analog results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion CTD PMID:26599973 5-methyltryptamine decreases activity EXP 6480464 5-methyltryptamine analog results in decreased activity of CYP2B6 protein CTD PMID:26599973 5alpha-androst-16-en-3alpha-ol multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [1 more ... CTD PMID:20361990 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions EXP 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:16608920 more ... 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases activity EXP 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:19202563 more ... 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases expression EXP 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:16608920 more ... 6-propyl-2-thiouracil affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Propylthiouracil affects the expression of CYP2B3 mRNA CTD PMID:19483382 6-propyl-2-thiouracil multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Iodine deficiency co-treated with Propylthiouracil] results in increased expression of CYP2B10 mRNA CTD PMID:22503787 7,12-dimethyltetraphene multiple interactions EXP 6480464 CYP2B6 protein results in increased metabolism of and results in increased activity of 9 more ... CTD PMID:32159784 9-cis-retinoic acid multiple interactions EXP 6480464 RXRA protein affects the reaction [Alitretinoin results in increased expression of CYP2B6 mRNA] CTD PMID:31312845 9-cis-retinoic acid increases expression EXP 6480464 Alitretinoin results in increased expression of CYP2B6 mRNA CTD PMID:31312845 acetamide decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 acetamide results in decreased expression of CYP2B3 mRNA CTD PMID:31881176 acetochlor increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of acetochlor CTD PMID:11133395 acifluorfen increases expression ISO Cyp2b10 (Mus musculus) 6480464 acifluorfen results in increased expression of CYP2B10 mRNA CTD PMID:26928356 acifluorfen multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 gene mutant form inhibits the reaction [acifluorfen results in increased expression of CYP2B10 mRNA] CTD PMID:26928356 acrylamide decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of CYP2B3 mRNA CTD PMID:28959563 actinomycin D multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Dactinomycin inhibits the reaction [Phenobarbital results in increased expression of CYP2B10 mRNA] CTD PMID:9007836 afimoxifene increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of afimoxifene CTD PMID:29285606 afimoxifene multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of afimoxifene] which results in increased abundance of afimoxifene metabolite CTD PMID:29285606 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of CYP2B6 protein CTD PMID:20106945 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CYP2B6 mRNA CTD PMID:27153756 aflatoxin B1 decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of CYP2B10 mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CYP2B6 mRNA CTD PMID:21994236 AICA ribonucleotide multiple interactions ISO Cyp2b3 (Rattus norvegicus) 6480464 AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA] and PRKAA2 protein promotes the reaction [AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]] CTD PMID:22815988 alachlor decreases response to substance EXP 6480464 CYP2B6 protein results in decreased susceptibility to alachlor CTD PMID:16277416 aldehydo-D-glucose multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP2B10 mRNA CTD PMID:37567420 aldrin increases expression EXP 6480464 Aldrin results in increased expression of CYP2B6 protein CTD PMID:15548381 all-trans-retinoic acid decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Tretinoin results in decreased activity of CYP2B10 protein CTD PMID:18420780 allyl isothiocyanate multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 allyl isothiocyanate inhibits the reaction [[1 more ... CTD PMID:25069801 allyl isothiocyanate multiple interactions EXP 6480464 allyl isothiocyanate inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:25069801 Aloe emodin multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of aloe emodin CTD PMID:29698620 Aloe emodin increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of aloe emodin CTD PMID:29698620 alpha-methyltryptamine decreases activity EXP 6480464 indopan analog results in decreased activity of CYP2B6 protein and indopan results in decreased activity of CYP2B6 protein CTD PMID:26599973 alpha-methyltryptamine multiple interactions EXP 6480464 [indopan analog results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion and [indopan results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion CTD PMID:26599973 aminoguanidine multiple interactions EXP 6480464 pimagedine inhibits the reaction [Phenytoin results in increased expression of CYP2B6 mRNA] CTD PMID:18206661 amiodarone affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Amiodarone affects the expression of CYP2B3 mRNA CTD PMID:19483382 amiodarone decreases response to substance EXP 6480464 CYP2B6 protein results in decreased susceptibility to Amiodarone CTD PMID:26477383 amiodarone increases expression ISO Cyp2b10 (Mus musculus) 6480464 Amiodarone results in increased expression of CYP2B10 mRNA CTD PMID:24535564 amitriptyline increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Amitriptyline CTD PMID:27320963 amitriptylinoxide increases abundance EXP 6480464 CYP2B6 protein results in increased abundance of amitriptyline N-oxide CTD PMID:27320963 amlodipine decreases activity EXP 6480464 Amlodipine results in decreased activity of CYP2B6 protein CTD PMID:10805063 amodiaquine multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of Amodiaquine] which results in increased abundance of desethylamodiaquine CTD PMID:31629065 amodiaquine increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Amodiaquine CTD PMID:31629065 amphetamine decreases methylation EXP 6480464 CYP2B6 protein results in decreased methylation of Amphetamine analog CTD PMID:29277574 amphetamine affects chemical synthesis EXP 6480464 CYP2B6 protein affects the chemical synthesis of Amphetamine CTD PMID:15294457 amphetamine increases hydroxylation EXP 6480464 CYP2B6 protein results in increased hydroxylation of Amphetamine analog CTD PMID:29277574 andrographolide increases activity ISO Cyp2b10 (Mus musculus) 6480464 andrographolide results in increased activity of CYP2B10 protein CTD PMID:21094198 andrographolide increases expression ISO Cyp2b10 (Mus musculus) 6480464 andrographolide results in increased expression of CYP2B10 mRNA CTD PMID:19737545 andrographolide multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B10 mRNA CTD PMID:19737545 androst-4-ene-3,17-dione increases expression ISO Cyp2b10 (Mus musculus) 6480464 Androstenedione results in increased expression of CYP2B10 mRNA CTD PMID:7771797 androst-4-ene-3,17-dione decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Androstenedione results in decreased expression of CYP2B10 mRNA CTD PMID:11075820 androstane multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Androstanols co-treated with fulvestrant] inhibits the reaction [DDT results in increased expression of CYP2B10 mRNA] more ... CTD PMID:12807759 and PMID:23684557 aniline multiple interactions EXP 6480464 CYP2B6 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 arachidonic acid increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Arachidonic Acid CTD PMID:12675279 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2B6 mRNA and Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2B6 protein CTD PMID:17851650 Aroclor 1254 decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP2B3 mRNA CTD PMID:18178546 arsane multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP2B10 mRNA CTD PMID:32045263 arsenic atom multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP2B10 mRNA CTD PMID:32045263 artemether multiple interactions EXP 6480464 [Artemether co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 atazanavir sulfate decreases expression EXP 6480464 Atazanavir Sulfate results in decreased expression of CYP2B6 mRNA CTD PMID:32152650 atazanavir sulfate multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA CTD PMID:32152650 atorvastatin calcium increases expression ISO Cyp2b10 (Mus musculus) 6480464 Atorvastatin results in increased expression of CYP2B10 mRNA and Atorvastatin results in increased expression of CYP2B10 protein CTD PMID:15986414 atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of CYP2B6 mRNA CTD PMID:15802384 atrazine multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 protein and Lycopene promotes the reaction [Atrazine results in increased expression of CYP2B10 mRNA] CTD PMID:22515965 and PMID:36216167 atrazine affects methylation ISO Cyp2b3 (Rattus norvegicus) 6480464 Atrazine affects the methylation of CYP2B3 gene CTD PMID:35440735 atrazine increases expression ISO Cyp2b10 (Mus musculus) 6480464 Atrazine results in increased expression of CYP2B10 mRNA CTD PMID:36216167 atrazine increases activity EXP 6480464 Atrazine results in increased activity of CYP2B6 protein CTD PMID:22310298 atrazine increases expression EXP 6480464 Atrazine results in increased expression of CYP2B6 mRNA CTD PMID:22310298 and PMID:22515965 atrazine multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 mRNA more ... CTD PMID:16608219 and PMID:22515965 Avasimibe increases expression EXP 6480464 avasimibe results in increased expression of CYP2B6 mRNA CTD PMID:15333513 Avasimibe multiple interactions EXP 6480464 avasimibe results in increased expression of and results in increased activity of CYP2B6 protein CTD PMID:15333513 azoxystrobin multiple interactions EXP 6480464 [cyproconazole co-treated with azoxystrobin] results in increased expression of CYP2B6 protein CTD PMID:29294346 azoxystrobin increases expression EXP 6480464 azoxystrobin results in increased expression of CYP2B6 protein CTD PMID:29294346 baicalein increases expression EXP 6480464 baicalein results in increased expression of CYP2B6 mRNA CTD PMID:25625231 barnidipine decreases activity EXP 6480464 mepirodipine results in decreased activity of CYP2B6 protein CTD PMID:10805063 benfuracarb increases expression EXP 6480464 benfuracarb results in increased expression of CYP2B6 mRNA CTD PMID:22310298 benfuracarb increases activity EXP 6480464 benfuracarb results in increased activity of CYP2B6 protein CTD PMID:22310298 benidipine increases expression EXP 6480464 benidipine results in increased expression of CYP2B6 mRNA and benidipine results in increased expression of CYP2B6 protein CTD PMID:27732883 benzbromarone affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Benzbromarone affects the expression of CYP2B3 mRNA CTD PMID:19483382 benzo[a]pyrene increases mutagenesis EXP 6480464 Benzo(a)pyrene results in increased mutagenesis of CYP2B6 gene CTD PMID:25435355 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CYP2B6 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of CYP2B6 exon CTD PMID:27901495 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of CYP2B6 3' UTR and Benzo(a)pyrene results in increased methylation of CYP2B6 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO Cyp2b10 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CYP2B10 mRNA and Benzo(a)pyrene results in increased expression of CYP2B10 protein CTD PMID:22228805 more ... benzo[a]pyrene multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CYP2B10 mRNA] CTD PMID:22228805 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 and PMID:33249052 benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of CYP2B6 mRNA CTD PMID:20106945 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CYP2B6 mRNA CTD PMID:15735009 benzo[a]pyrene diol epoxide I multiple interactions EXP 6480464 CYP2B6 gene SNP affects the reaction [7 more ... CTD PMID:22521834 benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I affects response to substance EXP 6480464 CYP2B6 gene SNP affects the susceptibility to 7 more ... CTD PMID:22521834 benzo[b]fluoranthene increases expression ISO Cyp2b10 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of CYP2B10 mRNA CTD PMID:26377693 Benzo[k]fluoranthene increases expression ISO Cyp2b10 (Mus musculus) 6480464 benzo(k)fluoranthene results in increased expression of CYP2B10 mRNA CTD PMID:26377693 benzphetamine increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Benzphetamine CTD PMID:12464242 and PMID:15769884 berberine multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Berberine inhibits the reaction [Streptozocin results in increased expression of CYP2B10 mRNA] and Berberine promotes the reaction [Phenobarbital results in increased expression of CYP2B10 mRNA] CTD PMID:22342832 berberine increases expression ISO Cyp2b10 (Mus musculus) 6480464 Berberine results in increased expression of CYP2B10 mRNA CTD PMID:22342832 bergomottin increases expression ISO Cyp2b10 (Mus musculus) 6480464 bergamottin results in increased expression of CYP2B10 protein CTD PMID:18692084 bergomottin decreases activity EXP 6480464 bergamottin results in decreased activity of CYP2B6 protein CTD PMID:15769884 beta-carboline multiple interactions EXP 6480464 CYP2B6 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 beta-hexachlorocyclohexane increases expression ISO Cyp2b10 (Mus musculus) 6480464 beta-hexachlorocyclohexane results in increased expression of CYP2B10 mRNA CTD PMID:25270620 beta-naphthoflavone increases activity EXP 6480464 beta-Naphthoflavone results in increased activity of CYP2B6 protein CTD PMID:19497361 and PMID:22258563 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CYP2B6 mRNA CTD PMID:19118567 beta-naphthoflavone multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B10 mRNA CTD PMID:19737545 bexarotene multiple interactions EXP 6480464 RXRA protein affects the reaction [Bexarotene results in increased expression of CYP2B6 mRNA] CTD PMID:31312845 bexarotene increases expression EXP 6480464 Bexarotene results in increased expression of CYP2B6 mRNA CTD PMID:31312845 bilirubin IXalpha increases expression EXP 6480464 Bilirubin results in increased expression of CYP2B6 mRNA CTD PMID:15382119 bilirubin IXalpha multiple interactions EXP 6480464 IL1B protein inhibits the reaction [Bilirubin results in increased expression of CYP2B6 mRNA] CTD PMID:15382119 bis(2-chloroethyl) sulfide increases expression ISO Cyp2b10 (Mus musculus) 6480464 Mustard Gas results in increased expression of CYP2B10 mRNA CTD PMID:15674844 bis(2-ethylhexyl) phthalate increases expression ISO Cyp2b10 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of CYP2B10 mRNA CTD PMID:17627975 more ... bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of CYP2B6 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:19850644 and PMID:30722647 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP2B6 mRNA CTD PMID:24793377 bisphenol A increases expression ISO Cyp2b10 (Mus musculus) 6480464 bisphenol A results in increased expression of CYP2B10 mRNA CTD PMID:33221593 bisphenol A multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28123100 and PMID:30722647 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP2B6 mRNA CTD PMID:26196221 bisphenol A decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of CYP2B6 mRNA CTD PMID:25181051 bosentan increases expression EXP 6480464 Bosentan results in increased expression of CYP2B6 mRNA CTD PMID:18332078 and PMID:29761207 brucine increases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 brucine results in increased expression of CYP2B3 protein CTD PMID:8850324 bupropion affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of Bupropion CTD PMID:15626586 bupropion increases metabolic processing ISO Cyp2b10 (Mus musculus) 6480464 CYP2B10 protein results in increased metabolism of Bupropion CTD PMID:25623066 bupropion multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [ABCB6 gene mutant form results in decreased expression of CYP2B10 mRNA] inhibits the reaction [CYP2B10 protein results in increased metabolism of Bupropion] and [ABCB6 gene mutant form results in decreased expression of CYP2B10 protein] inhibits the reaction [CYP2B10 protein results in increased metabolism of Bupropion] CTD PMID:25623066 bupropion increases hydroxylation EXP 6480464 CYP2B6 protein results in increased hydroxylation of Bupropion CTD PMID:22634058 more ... bupropion increases hydrolysis EXP 6480464 CYP2B6 protein results in increased hydrolysis of Bupropion CTD PMID:18611395 bupropion increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Bupropion CTD PMID:15155557 more ... bupropion multiple interactions EXP 6480464 2-(4'-methoxybenzenesulfonyl)-2 more ... CTD PMID:18611395 more ... buta-1,3-diene increases expression ISO Cyp2b10 (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of CYP2B10 mRNA CTD PMID:29038090 butachlor increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of butachlor CTD PMID:11133395 butylated hydroxyanisole increases expression ISO Cyp2b10 (Mus musculus) 6480464 Butylated Hydroxyanisole results in increased expression of CYP2B10 mRNA CTD PMID:17627975 Butylbenzyl phthalate increases expression ISO Cyp2b10 (Mus musculus) 6480464 butylbenzyl phthalate results in increased expression of CYP2B10 mRNA CTD PMID:26519955 butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of CYP2B6 mRNA CTD PMID:30439556 C.I. Natural Red 20 decreases activity EXP 6480464 shikonin results in decreased activity of CYP2B6 protein CTD PMID:28941798 C60 fullerene increases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 fullerene C60 results in increased expression of CYP2B3 mRNA CTD PMID:19167457 calciol increases expression EXP 6480464 Cholecalciferol metabolite results in increased expression of CYP2B6 CTD PMID:11991950 camphor multiple interactions EXP 6480464 Camphor inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 camptothecin decreases expression EXP 6480464 Camptothecin results in decreased expression of CYP2B6 mRNA CTD PMID:29356861 camptothecin multiple interactions EXP 6480464 Camptothecin inhibits the reaction [Rifampin results in increased expression of CYP2B6 mRNA] CTD PMID:29356861 cannabidiol decreases activity EXP 6480464 Cannabidiol results in decreased activity of CYP2B6 protein CTD PMID:24667653 cannabidiol increases expression ISO Cyp2b10 (Mus musculus) 6480464 Cannabidiol results in increased expression of CYP2B10 mRNA CTD PMID:31052254 cannabidiol multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CYP2B10 mRNA CTD PMID:33096940 cannabidiol decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Cannabidiol results in decreased activity of CYP2B10 CTD PMID:8043019 captan multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B10 mRNA and [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CYP2B10 mRNA CTD PMID:32736067 and PMID:32745781 captan increases expression ISO Cyp2b10 (Mus musculus) 6480464 Captan results in increased expression of CYP2B10 mRNA CTD PMID:31558096 carbamazepine multiple interactions EXP 6480464 [Carbamazepine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA and [Carbamazepine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 carbamazepine increases response to substance EXP 6480464 CYP2B6 protein results in increased susceptibility to Carbamazepine CTD PMID:36995427 carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of CYP2B6 mRNA and Carbamazepine results in increased expression of CYP2B6 protein CTD PMID:14977870 and PMID:17112801 carbaryl increases activity EXP 6480464 Carbaryl results in increased activity of CYP2B6 protein CTD PMID:22310298 carbaryl increases expression EXP 6480464 Carbaryl results in increased expression of CYP2B6 mRNA CTD PMID:22310298 carbendazim increases expression EXP 6480464 carbendazim results in increased expression of CYP2B6 mRNA CTD PMID:22310298 carbofuran increases activity EXP 6480464 Carbofuran results in increased activity of CYP2B6 protein CTD PMID:22310298 carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of CYP2B6 mRNA CTD PMID:22310298 carbosulfan increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of carbosulfan CTD PMID:20307514 carbosulfan increases expression EXP 6480464 carbosulfan results in increased expression of CYP2B6 mRNA CTD PMID:22310298 carbosulfan increases activity EXP 6480464 carbosulfan results in increased activity of CYP2B6 protein CTD PMID:22310298 cerivastatin increases expression EXP 6480464 cerivastatin results in increased expression of CYP2B6 mRNA CTD PMID:15802384 CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYP2B6 gene] CTD PMID:28238834 Chalepensin increases expression ISO Cyp2b10 (Mus musculus) 6480464 3-(alpha and alpha-dimethylallyl)psoralen results in increased expression of CYP2B10 mRNA CTD PMID:22790670 chenodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA more ... CTD PMID:32152650 and PMID:33819548 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of CYP2B6 protein CTD PMID:15548381 chlordecone increases expression ISO Cyp2b10 (Mus musculus) 6480464 Chlordecone results in increased expression of CYP2B10 mRNA CTD PMID:33711761 chlordecone multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Chlordecone results in increased expression of and results in increased activity of CYP2B10 protein CTD PMID:8722114 chlorfluazuron increases expression EXP 6480464 chlorfluazuron results in increased expression of CYP2B6 mRNA CTD PMID:22310298 chlorfluazuron increases activity EXP 6480464 chlorfluazuron results in increased activity of CYP2B6 protein CTD PMID:22310298 chlorotoluron multiple interactions EXP 6480464 CYP2B6 protein results in increased metabolism of and results in decreased susceptibility to chlortoluron CTD PMID:15853388 chlorpromazine multiple interactions EXP 6480464 [Chlorpromazine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA and Chlorpromazine inhibits the reaction [Androstenols inhibits the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA]] CTD PMID:10037683 and PMID:17041008 chlorpromazine decreases response to substance EXP 6480464 CYP2B6 protein results in decreased susceptibility to Chlorpromazine CTD PMID:26477383 chlorpromazine multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Chlorpromazine results in increased expression of CYP2B10 mRNA] CTD PMID:12049174 chlorpyrifos increases expression ISO Cyp2b10 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of CYP2B6 protein CTD PMID:22515965 chlorpyrifos decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of CYP2B10 mRNA CTD PMID:29935250 chlorpyrifos decreases activity EXP 6480464 Chlorpyrifos results in decreased activity of CYP2B6 protein CTD PMID:20183062 more ... chlorpyrifos increases activity EXP 6480464 CYP2B6 protein results in increased activity of Chlorpyrifos CTD PMID:22281205 chlorpyrifos increases metabolic processing EXP 6480464 CYP2B6 results in increased metabolism of Chlorpyrifos CTD PMID:20709133 chlorpyrifos decreases sulfation EXP 6480464 CYP2B6 protein results in decreased sulfation of Chlorpyrifos CTD PMID:17079358 chlorpyrifos affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of Chlorpyrifos CTD PMID:15557345 and PMID:17079358 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CYP2B6 mRNA and Chlorpyrifos results in increased expression of CYP2B6 protein CTD PMID:15548381 more ... chlorpyrifos multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 mRNA more ... CTD PMID:11854147 more ... chlorpyrifos multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 protein more ... CTD PMID:22515965 more ... cholesterol decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Cholesterol results in decreased activity of CYP2B10 protein CTD PMID:18420780 cholic acid increases expression ISO Cyp2b10 (Mus musculus) 6480464 Cholic Acid results in increased expression of CYP2B10 mRNA CTD PMID:17521389 choline multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA more ... CTD PMID:22872676 more ... chrysin increases expression EXP 6480464 chrysin results in increased expression of CYP2B6 mRNA CTD PMID:25625231 chrysin increases expression ISO Cyp2b10 (Mus musculus) 6480464 chrysin results in increased expression of CYP2B10 mRNA CTD PMID:25625231 chrysin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 gene mutant form inhibits the reaction [chrysin results in increased expression of CYP2B10 mRNA] CTD PMID:25625231 chrysophanol multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of aloe emodin CTD PMID:29698620 chrysophanol increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of chrysophanic acid CTD PMID:29698620 ciguatoxin CTX1B affects expression ISO Cyp2b10 (Mus musculus) 6480464 Ciguatoxins affects the expression of CYP2B10 mRNA CTD PMID:18353800 cimetidine decreases activity EXP 6480464 Cimetidine results in decreased activity of CYP2B6 protein CTD PMID:22733800 cimetidine multiple interactions EXP 6480464 [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2B6 protein CTD PMID:22733800 cimetidine decreases expression EXP 6480464 Cimetidine results in decreased expression of CYP2B6 protein CTD PMID:22733800 ciprofibrate multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 ciprofibrate inhibits the reaction [1 more ... CTD PMID:17962186 ciprofibrate decreases expression ISO Cyp2b10 (Mus musculus) 6480464 ciprofibrate results in decreased expression of CYP2B10 mRNA CTD PMID:27225895 citral multiple interactions EXP 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral more ... CTD PMID:18611395 and PMID:18824010 clemizole increases expression EXP 6480464 clemizole results in increased expression of CYP2B6 mRNA CTD PMID:31312845 clemizole multiple interactions EXP 6480464 [clemizole co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA and [clemizole co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 clofibrate affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Clofibrate affects the expression of CYP2B3 mRNA CTD PMID:19483382 clofibrate increases expression ISO Cyp2b10 (Mus musculus) 6480464 Clofibrate results in increased expression of CYP2B10 mRNA CTD PMID:17627975 clofibrate decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Clofibrate results in decreased expression of CYP2B3 mRNA CTD PMID:11328961 and PMID:18670166 clopidogrel increases oxidation EXP 6480464 CYP2B6 protein results in increased oxidation of clopidogrel CTD PMID:19812348 clopidogrel multiple interactions EXP 6480464 [Clopidogrel co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 clopidogrel increases expression EXP 6480464 Clopidogrel results in increased expression of CYP2B6 mRNA CTD PMID:31312845 clorgyline multiple interactions EXP 6480464 Clorgyline inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:25656918 clorgyline decreases activity EXP 6480464 Clorgyline results in decreased activity of CYP2B6 protein CTD PMID:25656918 clothianidin multiple interactions EXP 6480464 [clothianidin co-treated with thiacloprid] results in increased expression of CYP2B6 protein CTD PMID:32201337 clotrimazole increases activity EXP 6480464 Clotrimazole results in increased activity of CYP2B6 protein CTD PMID:14977870 clotrimazole multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Clotrimazole results in increased expression of CYP2B10 mRNA] CTD PMID:12049174 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of CYP2B6 protein CTD PMID:12571232 and PMID:14977870 clotrimazole multiple interactions EXP 6480464 Clotrimazole results in increased expression of and results in increased activity of CYP2B6 protein more ... CTD PMID:12695351 cobalt dichloride decreases expression ISO Cyp2b10 (Mus musculus) 6480464 cobaltous chloride results in decreased expression of CYP2B10 mRNA CTD PMID:21139344 cobalt dichloride decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 cobaltous chloride results in decreased expression of CYP2B3 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO Cyp2b10 (Mus musculus) 6480464 cobaltous chloride results in increased expression of CYP2B10 mRNA CTD PMID:23528251 copper(II) chloride multiple interactions EXP 6480464 [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of N'-nitrosonornicotine CTD PMID:32672941 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of CYP2B6 mRNA CTD PMID:19549813 corticosterone multiple interactions EXP 6480464 Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B6 mRNA] CTD PMID:35301062 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of CYP2B6 mRNA and Corticosterone results in increased expression of CYP2B6 protein CTD PMID:35301062 crocidolite asbestos decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of CYP2B10 mRNA CTD PMID:29279043 cumene hydroperoxide affects oxidation ISO Cyp2b3 (Rattus norvegicus) 6480464 CYP2B6 protein affects the oxidation of cumene hydroperoxide CTD PMID:17478480 cyanocob(III)alamin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA CTD PMID:33549593 cyclophosphamide multiple interactions EXP 6480464 [Cyclophosphamide results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA more ... CTD PMID:10919648 more ... cyclophosphamide increases activity ISO Cyp2b3 (Rattus norvegicus) 6480464 CYP2B6 protein results in increased activity of Cyclophosphamide CTD PMID:11723234 cyclophosphamide increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Cyclophosphamide CTD PMID:15769884 more ... cyclophosphamide increases expression ISO Cyp2b10 (Mus musculus) 6480464 Cyclophosphamide results in increased expression of CYP2B10 mRNA CTD PMID:24819615 cyclophosphamide increases hydroxylation EXP 6480464 CYP2B6 protein results in increased hydroxylation of Cyclophosphamide CTD PMID:12872138 more ... cyclophosphamide increases response to substance EXP 6480464 CYP2B6 protein results in increased susceptibility to Cyclophosphamide and CYP2B6 results in increased susceptibility to Cyclophosphamide CTD PMID:11389073 more ... cyclophosphamide affects hydroxylation EXP 6480464 CYP2B6 intron polymorphism affects the hydroxylation of Cyclophosphamide and CYP2B6 promoter polymorphism affects the hydroxylation of Cyclophosphamide CTD PMID:17502835 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CYP2B6 mRNA CTD PMID:20106945 and PMID:32152650 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CYP2B6 mRNA CTD PMID:34681664 cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA CTD PMID:32152650 cyhalothrin increases expression EXP 6480464 cyhalothrin results in increased expression of CYP2B6 mRNA CTD PMID:22310298 cyhalothrin multiple interactions EXP 6480464 cyhalothrin inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:22634058 cyhalothrin decreases activity EXP 6480464 cyhalothrin results in decreased activity of CYP2B6 protein CTD PMID:22634058 cyhalothrin increases activity EXP 6480464 cyhalothrin results in increased activity of CYP2B6 protein CTD PMID:22310298 cylindrospermopsin decreases activity EXP 6480464 cylindrospermopsin results in decreased activity of CYP2B6 protein CTD PMID:30905859 cylindrospermopsin decreases expression ISO Cyp2b10 (Mus musculus) 6480464 cylindrospermopsin results in decreased expression of CYP2B10 mRNA CTD PMID:20936652 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of CYP2B6 mRNA and cypermethrin results in increased expression of CYP2B6 protein CTD PMID:15548381 and PMID:22310298 cypermethrin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP2B10 mRNA] CTD PMID:31659573 cypermethrin increases expression ISO Cyp2b10 (Mus musculus) 6480464 cypermethrin results in increased expression of CYP2B10 mRNA CTD PMID:31659573 cypermethrin decreases activity ISO Cyp2b10 (Mus musculus) 6480464 cypermethrin results in decreased activity of CYP2B10 protein CTD PMID:18420780 cypermethrin increases activity EXP 6480464 cypermethrin results in increased activity of CYP2B6 protein CTD PMID:22310298 cyproconazole multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 promotes the reaction [cyproconazole results in increased expression of CYP2B10 mRNA] more ... CTD PMID:17557908 and PMID:25656644 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP2B6 mRNA and cyproconazole results in increased expression of CYP2B6 protein CTD PMID:28058446 more ... cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with azoxystrobin] results in increased expression of CYP2B6 protein more ... CTD PMID:28058446 and PMID:29294346 cyproconazole increases expression ISO Cyp2b10 (Mus musculus) 6480464 cyproconazole results in increased expression of CYP2B10 mRNA and cyproconazole results in increased expression of CYP2B10 protein CTD PMID:17557908 more ... cyproterone increases expression ISO Cyp2b10 (Mus musculus) 6480464 Cyproterone results in increased expression of CYP2B10 mRNA CTD PMID:7771797 cyproterone acetate increases expression ISO Cyp2b10 (Mus musculus) 6480464 Cyproterone Acetate results in increased expression of CYP2B10 mRNA CTD PMID:28541575 D-glucose multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP2B10 mRNA CTD PMID:37567420 dapsone multiple interactions EXP 6480464 CYP2B6 protein results in increased metabolism of and results in increased susceptibility to Dapsone CTD PMID:19998329 DDD increases expression EXP 6480464 Dichlorodiphenyldichloroethane results in increased expression of CYP2B6 mRNA CTD PMID:20686338 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP2B6 mRNA CTD PMID:20686338 DDE multiple interactions EXP 6480464 [CYP2B6 gene SNP affects the susceptibility to DDT] which affects the abundance of Dichlorodiphenyl Dichloroethylene and CYP2B6 gene SNP affects the reaction [DDT results in increased abundance of Dichlorodiphenyl Dichloroethylene] CTD PMID:27839851 DDT increases expression EXP 6480464 DDT results in increased expression of CYP2B6 mRNA and DDT results in increased expression of CYP2B6 protein CTD PMID:15548381 and PMID:20686338 DDT decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 DDT results in decreased expression of CYP2B3 mRNA CTD PMID:29477483 DDT multiple interactions EXP 6480464 [CYP2B6 gene SNP affects the susceptibility to DDT] which affects the abundance of Dichlorodiphenyl Dichloroethylene and CYP2B6 gene SNP affects the reaction [DDT results in increased abundance of Dichlorodiphenyl Dichloroethylene] CTD PMID:27839851 DDT increases expression ISO Cyp2b10 (Mus musculus) 6480464 DDT results in increased expression of CYP2B10 mRNA CTD PMID:23684557 DDT multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Androstanols co-treated with fulvestrant] inhibits the reaction [DDT results in increased expression of CYP2B10 mRNA] more ... CTD PMID:23684557 decabromodiphenyl ether multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I2 protein promotes the reaction [decabromobiphenyl ether results in increased expression of CYP2B10 mRNA] and NR1I3 gene mutant form inhibits the reaction [decabromobiphenyl ether results in increased expression of CYP2B10 mRNA] CTD PMID:17324954 and PMID:23531792 decabromodiphenyl ether increases expression ISO Cyp2b10 (Mus musculus) 6480464 decabromobiphenyl ether results in increased expression of CYP2B10 mRNA CTD PMID:17324954 and PMID:23531792 Dechloroethylcyclophosphamide affects chemical synthesis EXP 6480464 CYP2B6 protein affects the chemical synthesis of dechloroethylcyclophosphamide CTD PMID:15875221 deoxycholic acid increases expression EXP 6480464 Deoxycholic Acid metabolite results in increased expression of CYP2B6 mRNA CTD PMID:27871908 deoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA more ... CTD PMID:32152650 and PMID:33819548 dexamethasone multiple interactions EXP 6480464 Dexamethasone promotes the reaction [NR3C1 protein affects the reaction [NR1I2 protein promotes the reaction [Clotrimazole results in increased expression of CYP2B6 mRNA]]] more ... CTD PMID:12695351 and PMID:15802389 dexamethasone increases expression ISO Cyp2b10 (Mus musculus) 6480464 Dexamethasone results in increased expression of CYP2B10 mRNA CTD PMID:17627975 more ... dexamethasone decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of CYP2B3 mRNA CTD PMID:11328961 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CYP2B6 mRNA and Dexamethasone results in increased expression of CYP2B6 protein CTD PMID:15548381 more ... dextran sulfate multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP2B10 mRNA CTD PMID:29950665 dextromethorphan decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Dextromethorphan results in decreased activity of CYP2B10 protein CTD PMID:18420780 diallyl disulfide increases expression EXP 6480464 diallyl disulfide results in increased expression of CYP2B1 mRNA and diallyl disulfide results in increased expression of CYP2B2 mRNA CTD PMID:17353348 Diallyl sulfide multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 protein promotes the reaction [allyl sulfide results in increased expression of CYP2B10 mRNA] CTD PMID:17353348 Diallyl sulfide increases expression ISO Cyp2b10 (Mus musculus) 6480464 allyl sulfide results in increased expression of CYP2B10 mRNA CTD PMID:15919853 more ... Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of CYP2B1 mRNA more ... CTD PMID:17353348 diarylheptanoid decreases activity EXP 6480464 Diarylheptanoids results in decreased activity of CYP2B6 protein CTD PMID:23850985 diarylheptanoid increases expression EXP 6480464 Diarylheptanoids results in increased expression of CYP2B6 mRNA CTD PMID:23850985 diazepam increases expression ISO Cyp2b10 (Mus musculus) 6480464 Diazepam results in increased expression of CYP2B10 protein CTD PMID:16684660 diazinon affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of Diazinon CTD PMID:15557345 and PMID:15764407 diazinon multiple interactions EXP 6480464 CYP2B6 protein results in decreased sulfation of and results in increased activity of Diazinon CTD PMID:15764407 dibenz[a,h]anthracene increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of 1 more ... CTD PMID:8638931 dibenz[a,h]anthracene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 and PMID:8638931 diclofenac decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Diclofenac results in decreased activity of CYP2B10 protein CTD PMID:18420780 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of CYP2B6 protein CTD PMID:15548381 dieldrin increases expression ISO Cyp2b10 (Mus musculus) 6480464 Dieldrin results in increased expression of CYP2B10 mRNA CTD PMID:32435917 dieldrin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Dieldrin results in increased expression of CYP2B10 mRNA] CTD PMID:12049174 and PMID:32435917 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CYP2B6 mRNA CTD PMID:21924250 difenoconazole multiple interactions EXP 6480464 [difenoconazole co-treated with fludioxonil] results in increased expression of CYP2B6 mRNA CTD PMID:33575850 difenoconazole increases expression ISO Cyp2b10 (Mus musculus) 6480464 difenoconazole results in increased expression of CYP2B10 mRNA CTD PMID:34425431 difenoconazole increases expression EXP 6480464 difenoconazole results in increased expression of CYP2B6 mRNA CTD PMID:33575850 digitonin increases expression ISO Cyp2b10 (Mus musculus) 6480464 Digitonin results in increased expression of CYP2B10 protein CTD PMID:36030841 dihydroergotamine decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Dihydroergotamine results in decreased activity of CYP2B10 protein CTD PMID:18420780 diiodine multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Iodine deficiency co-treated with Propylthiouracil] results in increased expression of CYP2B10 mRNA CTD PMID:22503787 dimemorfan increases oxidation EXP 6480464 CYP2B6 protein results in increased oxidation of dimemorfan CTD PMID:19593786 dimethyl sulfoxide multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Phenobarbital co-treated with Dimethyl Sulfoxide] results in increased expression of CYP2B10 protein and NR1I3 gene mutant form inhibits the reaction [[Phenobarbital co-treated with Dimethyl Sulfoxide] results in increased expression of CYP2B10 protein] CTD PMID:20371638 dimethyl sulfoxide multiple interactions EXP 6480464 [Dimethyl Sulfoxide co-treated with TGFB1 protein] results in decreased expression of CYP2B6 mRNA and [Dimethyl Sulfoxide co-treated with TGFB1 protein] results in decreased expression of CYP2B6 protein CTD PMID:35366062 dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of CYP2B6 mRNA and Dimethyl Sulfoxide results in increased expression of CYP2B6 protein CTD PMID:30262279 and PMID:31096615 diquat increases expression ISO Cyp2b10 (Mus musculus) 6480464 Diquat results in increased expression of CYP2B10 mRNA CTD PMID:36851058 disodium selenite multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP2B10 mRNA] CTD PMID:31659573 diuron increases expression EXP 6480464 Diuron results in increased expression of CYP2B6 mRNA CTD PMID:22310298 domperidone increases hydroxylation EXP 6480464 CYP2B6 protein results in increased hydroxylation of Domperidone CTD PMID:15327587 doxorubicin multiple interactions EXP 6480464 [Doxorubicin co-treated with Cyclophosphamide] affects the expression of CYP2B6 mRNA CTD PMID:16322899 dronedarone increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of dronedarone CTD PMID:29616291 efavirenz affects metabolic processing EXP 6480464 CYP2B6 gene polymorphism affects the metabolism of efavirenz and CYP2B6 protein affects the metabolism of efavirenz CTD PMID:15622315 and PMID:17559344 efavirenz decreases activity EXP 6480464 efavirenz results in decreased activity of CYP2B6 protein CTD PMID:26599973 efavirenz multiple interactions EXP 6480464 [efavirenz results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion more ... CTD PMID:17041008 and PMID:26599973 efavirenz increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of efavirenz CTD PMID:15769884 and PMID:17559344 elemental selenium increases expression ISO Cyp2b10 (Mus musculus) 6480464 Selenium deficiency results in increased expression of CYP2B10 mRNA CTD PMID:16170372 endosulfan multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 protein and [Endosulfan inhibits the reaction [androst-16-en-3-ol results in decreased activity of NR1I3 protein]] which results in increased expression of CYP2B6 mRNA CTD PMID:20361990 and PMID:22515965 endosulfan increases expression ISO Cyp2b10 (Mus musculus) 6480464 Endosulfan analog results in increased expression of CYP2B10 mRNA and Endosulfan results in increased expression of CYP2B10 mRNA CTD PMID:29702342 endosulfan increases activity EXP 6480464 Endosulfan results in increased activity of CYP2B6 protein CTD PMID:24832206 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CYP2B6 mRNA and Endosulfan results in increased expression of CYP2B6 protein CTD PMID:15548381 more ... endosulfan affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of Endosulfan CTD PMID:16581944 and PMID:16855053 endosulfan multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 mRNA more ... CTD PMID:16855053 more ... endrin increases expression EXP 6480464 Endrin results in increased expression of CYP2B6 protein CTD PMID:15548381 enilconazole increases expression ISO Cyp2b10 (Mus musculus) 6480464 enilconazole results in increased expression of CYP2B10 CTD PMID:27853109 enilconazole multiple interactions EXP 6480464 [enilconazole co-treated with thiacloprid] results in increased expression of CYP2B6 protein more ... CTD PMID:32201337 enilconazole affects expression EXP 6480464 enilconazole affects the expression of CYP2B6 mRNA CTD PMID:32201337 epoxiconazole increases expression ISO Cyp2b10 (Mus musculus) 6480464 epoxiconazole results in increased expression of CYP2B10 mRNA CTD PMID:22334560 and PMID:23970803 epoxiconazole decreases expression ISO Cyp2b10 (Mus musculus) 6480464 epoxiconazole results in decreased expression of CYP2B10 mRNA CTD PMID:35436446 epoxiconazole multiple interactions EXP 6480464 [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 mRNA and [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 protein CTD PMID:29294346 Erionite decreases expression ISO Cyp2b10 (Mus musculus) 6480464 erionite results in decreased expression of CYP2B10 mRNA CTD PMID:29279043 erlotinib hydrochloride increases expression EXP 6480464 Erlotinib Hydrochloride results in increased expression of CYP2B6 mRNA CTD PMID:30364229 estriol increases expression ISO Cyp2b10 (Mus musculus) 6480464 Estriol results in increased expression of CYP2B10 mRNA CTD PMID:7771797 estrone increases expression ISO Cyp2b10 (Mus musculus) 6480464 Estrone results in increased expression of CYP2B10 mRNA CTD PMID:11075820 more ... ethanol increases expression ISO Cyp2b10 (Mus musculus) 6480464 Ethanol results in increased expression of CYP2B10 mRNA and Ethanol results in increased expression of CYP2B10 protein CTD PMID:19167417 and PMID:27765815 ethanol multiple interactions EXP 6480464 Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B6 mRNA] CTD PMID:35301062 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP2B6 mRNA and Ethanol results in increased expression of CYP2B6 protein CTD PMID:35301062 ethanol multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Ethanol promotes the reaction [SP1 protein binds to CYP2B10 promoter] more ... CTD PMID:27765815 ethoxyquin increases expression ISO Cyp2b10 (Mus musculus) 6480464 Ethoxyquin results in increased expression of CYP2B10 mRNA CTD PMID:17627975 farnesol multiple interactions EXP 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of CYP2B6 mRNA and Farnesol analog inhibits the reaction [Oleic Acid results in decreased expression of CYP2B6 mRNA] CTD PMID:30611723 farnesol increases expression EXP 6480464 Farnesol analog results in increased expression of CYP2B6 mRNA and Farnesol results in increased expression of CYP2B6 mRNA CTD PMID:30611723 felodipine increases expression EXP 6480464 Felodipine results in increased expression of CYP2B6 mRNA and Felodipine results in increased expression of CYP2B6 protein CTD PMID:27732883 fenbuconazole multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 fenbuconazole binds to and results in increased activity of CYP2B10 protein CTD PMID:16542693 fenbuconazole increases expression ISO Cyp2b10 (Mus musculus) 6480464 fenbuconazole results in increased expression of CYP2B10 protein CTD PMID:16542693 fenitrothion increases expression EXP 6480464 Fenitrothion results in increased expression of CYP2B6 mRNA CTD PMID:22310298 fenitrothion decreases activity EXP 6480464 Fenitrothion results in decreased activity of CYP2B6 protein CTD PMID:20183062 more ... fenitrothion multiple interactions EXP 6480464 Fenitrothion inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:22634058 fenofibrate increases expression ISO Cyp2b10 (Mus musculus) 6480464 Fenofibrate results in increased expression of CYP2B10 mRNA CTD PMID:11798191 fenproporex decreases alkylation EXP 6480464 CYP2B6 protein results in decreased alkylation of fenproporex CTD PMID:15294457 fentanyl increases activity ISO Cyp2b10 (Mus musculus) 6480464 Fentanyl results in increased activity of CYP2B6 protein CTD PMID:35914676 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of CYP2B6 mRNA and fenvalerate results in increased expression of CYP2B6 protein CTD PMID:15548381 and PMID:22310298 fenvalerate multiple interactions EXP 6480464 fenvalerate inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:22634058 fenvalerate decreases activity EXP 6480464 fenvalerate results in decreased activity of CYP2B6 protein CTD PMID:22634058 fenvalerate increases activity EXP 6480464 fenvalerate results in increased activity of CYP2B6 protein CTD PMID:22310298 finasteride increases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Finasteride results in increased expression of CYP2B3 protein CTD PMID:27750143 fipronil multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 gene mutant form inhibits the reaction [fipronil results in increased expression of CYP2B10 mRNA] CTD PMID:23962444 fipronil increases expression EXP 6480464 fipronil results in increased expression of CYP2B6 mRNA CTD PMID:17084830 and PMID:27091632 fipronil multiple interactions EXP 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2B6 mRNA CTD PMID:27091632 fipronil increases expression ISO Cyp2b10 (Mus musculus) 6480464 fipronil results in increased expression of CYP2B10 mRNA CTD PMID:23962444 flavonoids decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Flavonoids results in decreased expression of CYP2B6 mRNA CTD PMID:18035473 fluconazole multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 promotes the reaction [Fluconazole results in increased expression of CYP2B10 mRNA] CTD PMID:25656644 fluconazole increases expression ISO Cyp2b10 (Mus musculus) 6480464 Fluconazole results in increased expression of CYP2B10 mRNA CTD PMID:16730040 and PMID:25656644 fludioxonil multiple interactions EXP 6480464 [difenoconazole co-treated with fludioxonil] results in increased expression of CYP2B6 mRNA more ... CTD PMID:33575850 fludioxonil increases expression EXP 6480464 fludioxonil results in increased expression of CYP2B6 mRNA CTD PMID:33575850 flumequine multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 fluoranthene increases expression EXP 6480464 fluoranthene results in increased expression of CYP2B6 mRNA CTD PMID:33249052 fluoranthene multiple interactions EXP 6480464 [fluoranthene co-treated with Benzo(a)pyrene] inhibits the reaction [pyrene results in increased expression of CYP2B6 mRNA] more ... CTD PMID:33249052 flutamide decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of CYP2B3 mRNA CTD PMID:24136188 flutamide increases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Flutamide results in increased expression of CYP2B3 mRNA CTD PMID:24793618 fluvastatin increases expression EXP 6480464 fluvastatin results in increased expression of CYP2B6 mRNA CTD PMID:15802384 fluxapyroxad increases expression EXP 6480464 fluxapyroxad results in increased expression of CYP2B6 mRNA and fluxapyroxad results in increased expression of CYP2B6 protein CTD PMID:29294346 fluxapyroxad multiple interactions EXP 6480464 [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 mRNA and [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 protein CTD PMID:29294346 folic acid multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CYP2B10 mRNA CTD PMID:22872676 and PMID:33549593 fructose multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP2B10 mRNA CTD PMID:37567420 fulvestrant multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Androstanols co-treated with fulvestrant] inhibits the reaction [DDT results in increased expression of CYP2B10 mRNA] CTD PMID:23684557 furathiocarb increases expression EXP 6480464 deltanit results in increased expression of CYP2B6 mRNA CTD PMID:22310298 furathiocarb increases activity EXP 6480464 deltanit results in increased activity of CYP2B6 protein CTD PMID:22310298 galangin increases expression EXP 6480464 galangin results in increased expression of CYP2B6 mRNA CTD PMID:25625231 gallocatechin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA CTD PMID:25663641 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of CYP2B6 mRNA and Hexachlorocyclohexane results in increased expression of CYP2B6 protein CTD PMID:15548381 and PMID:20035023 geranial multiple interactions EXP 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral more ... CTD PMID:18611395 and PMID:18824010 geraniol multiple interactions EXP 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral more ... CTD PMID:18611395 and PMID:18824010 geraniol increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of geraniol CTD PMID:18824010 Ginkgolide A increases expression EXP 6480464 ginkgolide A results in increased expression of CYP2B6 mRNA CTD PMID:19034627 ginkgolide B increases expression EXP 6480464 ginkgolide B results in increased expression of CYP2B6 mRNA CTD PMID:19034627 ginsenoside Rg1 multiple interactions ISO Cyp2b3 (Rattus norvegicus) 6480464 ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA] and ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 protein] CTD PMID:32198087 glucose multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP2B10 mRNA CTD PMID:37567420 glutathione multiple interactions EXP 6480464 [CYP2B6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac more ... CTD PMID:24246759 and PMID:32198085 glycine betaine multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA CTD PMID:33549593 glycochenodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA more ... CTD PMID:32152650 and PMID:33819548 glycocholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA more ... CTD PMID:32152650 and PMID:33819548 glycodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA more ... CTD PMID:32152650 and PMID:33819548 griseofulvin affects expression ISO Cyp2b10 (Mus musculus) 6480464 Griseofulvin affects the expression of CYP2B10 mRNA CTD PMID:12735108 guggulsterone affects expression ISO Cyp2b10 (Mus musculus) 6480464 pregna-4 more ... CTD PMID:15833898 GW 3965 multiple interactions EXP 6480464 GW 3965 inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:23732298 GW 4064 decreases expression EXP 6480464 GW 4064 results in decreased expression of CYP2B6 mRNA CTD PMID:30611723 GW 4064 multiple interactions EXP 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of CYP2B6 mRNA CTD PMID:30611723 GW 7647 multiple interactions EXP 6480464 [GW 7647 co-treated with Oleic Acid] results in decreased expression of CYP2B6 mRNA CTD PMID:30611723 GW 7647 increases expression EXP 6480464 GW 7647 results in increased expression of CYP2B6 mRNA CTD PMID:31676336 halothane increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Halothane CTD PMID:11684365 helenalin increases oxidation EXP 6480464 CYP2B6 protein results in increased oxidation of helenalin CTD PMID:34989853 herbicide multiple interactions EXP 6480464 [CYP1A1 protein co-treated with CYP2B6 protein co-treated with CYP2C19 protein] results in decreased susceptibility to Herbicides CTD PMID:16608219 heroin increases activity ISO Cyp2b10 (Mus musculus) 6480464 Heroin results in increased activity of CYP2B6 protein CTD PMID:35914676 hexaflumuron increases activity EXP 6480464 hexafluoron results in increased activity of CYP2B6 protein CTD PMID:22310298 hexaflumuron increases expression EXP 6480464 hexafluoron results in increased expression of CYP2B6 mRNA CTD PMID:22310298 hexane increases hydroxylation EXP 6480464 CYP2B1 protein results in increased hydroxylation of n-hexane and CYP2B6 protein results in increased hydroxylation of n-hexane CTD PMID:16484137 hydroquinone affects response to substance EXP 6480464 CYP2B1 protein affects the susceptibility to hydroquinone CTD PMID:8242868 Hydroxybupropion multiple interactions EXP 6480464 [CYP2B6 protein results in increased hydroxylation of Bupropion] which results in increased chemical synthesis of hydroxybupropion more ... CTD PMID:21915887 more ... Hydroxybupropion increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of hydroxybupropion CTD PMID:21915887 and PMID:23850985 hyperforin increases expression EXP 6480464 hyperforin results in increased expression of CYP2B6 mRNA CTD PMID:24259679 ifosfamide affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of Ifosfamide CTD PMID:15875221 ifosfamide multiple interactions EXP 6480464 POR promotes the reaction [CYP2B6 results in increased susceptibility to Ifosfamide] CTD PMID:9766669 ifosfamide increases response to substance EXP 6480464 CYP2B6 results in increased susceptibility to Ifosfamide CTD PMID:9766669 imidacloprid increases expression ISO Cyp2b10 (Mus musculus) 6480464 imidacloprid results in increased expression of CYP2B10 mRNA CTD PMID:36320626 imidazoles multiple interactions EXP 6480464 Imidazoles inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:21778469 imipramine oxide increases abundance EXP 6480464 CYP2B6 protein results in increased abundance of imipramine N-oxide CTD PMID:27320963 imperatorin increases expression ISO Cyp2b10 (Mus musculus) 6480464 imperatorin results in increased expression of CYP2B10 protein CTD PMID:18692084 indometacin decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Indomethacin results in decreased expression of CYP2B3 mRNA and Indomethacin results in decreased expression of CYP2B6 mRNA CTD PMID:16771604 inulin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYP2B10 mRNA CTD PMID:36331819 isoimperatorin increases oxidation EXP 6480464 CYP2B6 protein results in increased oxidation of isoimperatorin CTD PMID:25500267 isoimperatorin multiple interactions EXP 6480464 [isoimperatorin co-treated with NADP] results in decreased activity of CYP2B6 protein and Mephenytoin inhibits the reaction [[isoimperatorin co-treated with NADP] results in decreased activity of CYP2B6 protein] CTD PMID:25500267 isopimpinellin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 protein affects the reaction [isopimpinellin results in increased expression of CYP2B10 mRNA] CTD PMID:18692084 isopimpinellin increases expression ISO Cyp2b10 (Mus musculus) 6480464 isopimpinellin results in increased expression of CYP2B10 mRNA and isopimpinellin results in increased expression of CYP2B10 protein CTD PMID:18692084 isoprenaline increases expression ISO Cyp2b10 (Mus musculus) 6480464 Isoproterenol results in increased expression of CYP2B10 mRNA CTD PMID:20003209 isoproturon increases expression EXP 6480464 isoproturon results in increased expression of CYP2B6 mRNA CTD PMID:22310298 isoproturon increases activity EXP 6480464 isoproturon results in increased activity of CYP2B6 protein CTD PMID:22310298 isoxazoles affects activity EXP 6480464 Isoxazoles analog affects the activity of CYP2B6 protein CTD PMID:21924250 isoxazoles increases expression EXP 6480464 Isoxazoles analog results in increased expression of CYP2B6 mRNA CTD PMID:21924250 Isradipine increases expression EXP 6480464 Isradipine results in increased expression of CYP2B6 mRNA and Isradipine results in increased expression of CYP2B6 protein CTD PMID:27732883 ivermectin decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Ivermectin results in decreased activity of CYP2B10 protein CTD PMID:18420780 ivermectin increases expression ISO Cyp2b10 (Mus musculus) 6480464 Ivermectin results in increased expression of CYP2B10 mRNA CTD PMID:24998875 ketoconazole decreases activity EXP 6480464 Ketoconazole results in decreased activity of CYP2B6 protein CTD PMID:14709627 ketoconazole increases expression ISO Cyp2b10 (Mus musculus) 6480464 Ketoconazole results in increased expression of CYP2B10 mRNA CTD PMID:17966066 ketoconazole multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:16608920 and PMID:17438109 ketoconazole decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Ketoconazole results in decreased activity of CYP2B10 protein CTD PMID:18420780 kojic acid multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B10 mRNA CTD PMID:17917374 L-ascorbic acid multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B10 mRNA CTD PMID:17917374 L-ethionine affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Ethionine affects the expression of CYP2B3 mRNA CTD PMID:19483382 L-methionine multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA more ... CTD PMID:22872676 more ... lactacystin multiple interactions EXP 6480464 lactacystin inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:24224465 lamotrigine increases glutathionylation EXP 6480464 CYP2B6 protein results in increased glutathionylation of lamotrigine CTD PMID:19961160 lead diacetate decreases expression ISO Cyp2b10 (Mus musculus) 6480464 lead acetate results in decreased expression of CYP2B10 mRNA CTD PMID:21829687 lefetamine decreases alkylation EXP 6480464 CYP2B6 protein results in decreased alkylation of lephetamine CTD PMID:26276083 leflunomide increases expression EXP 6480464 Leflunomide results in increased expression of CYP2B6 mRNA CTD PMID:30364229 lithocholic acid decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Lithocholic Acid results in decreased activity of CYP2B10 protein CTD PMID:18420780 lithocholic acid increases expression ISO Cyp2b10 (Mus musculus) 6480464 Lithocholic Acid results in increased expression of CYP2B10 mRNA CTD PMID:15358766 lithocholic acid multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [1 more ... CTD PMID:15358766 more ... lycopene multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Lycopene promotes the reaction [Atrazine results in increased expression of CYP2B10 mRNA] CTD PMID:36216167 malathion affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of Malathion CTD PMID:15557345 malathion multiple interactions EXP 6480464 Malathion promotes the reaction [isomalathion results in increased expression of CYP2B6 mRNA] CTD PMID:24333466 malathion decreases activity EXP 6480464 Malathion results in decreased activity of CYP2B6 protein CTD PMID:22310298 malathion increases expression EXP 6480464 Malathion results in increased expression of CYP2B6 mRNA CTD PMID:22310298 mancozeb decreases expression EXP 6480464 mancozeb results in decreased expression of CYP2B6 protein CTD PMID:31096615 Meclizine multiple interactions EXP 6480464 Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP2B10 mRNA] CTD PMID:15272053 Meclizine multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Meclizine binds to and results in increased activity of NR1I3 protein] which results in increased expression of CYP2B10 mRNA CTD PMID:15272053 mefenacet multiple interactions EXP 6480464 CYP2B6 protein results in increased metabolism of and results in decreased susceptibility to mefenacet CTD PMID:15853388 MeIQx multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 mephenytoin decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Mephenytoin results in decreased activity of CYP2B10 protein CTD PMID:18420780 mephenytoin decreases activity EXP 6480464 Mephenytoin results in decreased activity of CYP2B6 protein CTD PMID:9241656 mephenytoin increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Mephenytoin CTD PMID:12464242 mephenytoin multiple interactions EXP 6480464 Mephenytoin inhibits the reaction [[isoimperatorin co-treated with NADP] results in decreased activity of CYP2B6 protein] more ... CTD PMID:25500267 and PMID:9241656 mephenytoin decreases methylation EXP 6480464 CYP2B6 protein results in decreased methylation of Mephenytoin CTD PMID:12433797 mercury dichloride increases expression ISO Cyp2b10 (Mus musculus) 6480464 Mercuric Chloride results in increased expression of CYP2B10 mRNA CTD PMID:24472606 metazachlor increases expression EXP 6480464 metazachlor results in increased expression of CYP2B6 mRNA CTD PMID:31465819 metformin increases expression ISO Cyp2b10 (Mus musculus) 6480464 Metformin results in increased expression of CYP2B10 mRNA CTD PMID:22342832 methidathion increases expression ISO Cyp2b10 (Mus musculus) 6480464 methidathion results in increased expression of CYP2B10 mRNA CTD PMID:34813904 methiocarb increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Methiocarb CTD PMID:27665777 methiocarb multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide CTD PMID:27665777 methiocarb-sulfoxide multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide CTD PMID:27665777 methiocarb-sulfoxide increases abundance EXP 6480464 CYP2B6 protein results in increased abundance of methiocarb sulfoxide CTD PMID:27665777 methoxsalen decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Methoxsalen results in decreased activity of CYP2B10 protein CTD PMID:18420780 methoxychlor increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Methoxychlor CTD PMID:12464242 methoxychlor increases activity EXP 6480464 Methoxychlor results in increased activity of CYP2B6 protein CTD PMID:24832206 methoxychlor decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Methoxychlor results in decreased activity of CYP2B10 protein CTD PMID:18420780 methoxychlor increases hydroxylation EXP 6480464 CYP2B6 protein results in increased hydroxylation of Methoxychlor CTD PMID:10101147 more ... methoxychlor decreases methylation EXP 6480464 CYP2B6 protein results in decreased methylation of Methoxychlor CTD PMID:12167570 more ... methoxychlor decreases activity EXP 6480464 Methoxychlor results in decreased activity of CYP2B6 protein CTD PMID:9241656 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of CYP2B6 mRNA and Methoxychlor results in increased expression of CYP2B6 protein CTD PMID:15548381 more ... methoxychlor multiple interactions EXP 6480464 [Endosulfan co-treated with Methoxychlor] results in decreased activity of CYP2B6 protein more ... CTD PMID:10037683 more ... methoxyflurane increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Methoxyflurane CTD PMID:7879937 methylisothiazolinone increases expression EXP 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of CYP2B6 mRNA CTD PMID:31629900 metolachlor multiple interactions EXP 6480464 [CYP1A1 protein co-treated with CYP2B6 protein co-treated with CYP2C19 protein] results in decreased susceptibility to [norflurazone co-treated with metolachlor co-treated with Atrazine] more ... CTD PMID:15853388 more ... metolachlor increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of metolachlor CTD PMID:11133395 midazolam decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Midazolam results in decreased activity of CYP2B10 protein CTD PMID:18420780 mifepristone multiple interactions EXP 6480464 [Mifepristone results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 mirex multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Mirex results in increased expression of and results in increased activity of CYP2B10 protein CTD PMID:8722114 Mitotane multiple interactions EXP 6480464 [Mitotane co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA and [Mitotane co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 Mitotane increases expression EXP 6480464 Mitotane results in increased expression of CYP2B6 mRNA CTD PMID:31312845 Mitotane affects abundance EXP 6480464 CYP2B6 gene polymorphism affects the abundance of Mitotane and CYP2B6 protein affects the abundance of Mitotane CTD PMID:23524664 monocrotaline multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP2B10 mRNA CTD PMID:21224054 monocrotophos multiple interactions EXP 6480464 [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2B6 protein more ... CTD PMID:22733800 monocrotophos increases expression EXP 6480464 Monocrotophos results in increased expression of CYP2B6 mRNA and Monocrotophos results in increased expression of CYP2B6 protein CTD PMID:22733800 monocrotophos increases activity EXP 6480464 Monocrotophos results in increased activity of CYP2B6 protein CTD PMID:22733800 monosodium L-glutamate increases expression ISO Cyp2b10 (Mus musculus) 6480464 Sodium Glutamate results in increased expression of CYP2B10 mRNA CTD PMID:20111022 monosodium L-glutamate multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA more ... CTD PMID:19001666 more ... moricizine increases expression EXP 6480464 Moricizine results in increased expression of CYP2B6 mRNA CTD PMID:18332078 morphine increases activity ISO Cyp2b10 (Mus musculus) 6480464 Morphine results in increased activity of CYP2B6 protein CTD PMID:35914676 N'-Nitrosonornicotine multiple interactions EXP 6480464 [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of N'-nitrosonornicotine CTD PMID:32672941 N,N-diethyl-m-toluamide increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of DEET CTD PMID:11854147 N,N-diethyl-m-toluamide increases expression EXP 6480464 DEET results in increased expression of CYP2B6 mRNA CTD PMID:19326769 more ... N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2B6 mRNA and Chlorpyrifos inhibits the reaction [CYP2B6 protein results in increased metabolism of DEET] CTD PMID:11854147 and PMID:27091632 N,N-diisopropyltryptamine decreases activity EXP 6480464 N and N-diisopropyltryptamine analog results in decreased activity of CYP2B6 protein CTD PMID:26599973 N,N-diisopropyltryptamine multiple interactions EXP 6480464 [N and N-diisopropyltryptamine analog results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion CTD PMID:26599973 N-[3-(aminomethyl)benzyl]acetamidine multiple interactions EXP 6480464 N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Phenytoin results in increased expression of CYP2B6 mRNA] CTD PMID:18206661 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:24224465 N-Nitrosodi-n-propylamine affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of N-nitroso(di-n-propyl)amine CTD PMID:10910959 N-nitrosodiethylamine multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [2 more ... CTD PMID:15492232 more ... NADP zwitterion multiple interactions EXP 6480464 [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone more ... CTD PMID:11805216 more ... NADP(+) multiple interactions EXP 6480464 [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone more ... CTD PMID:11805216 more ... nefazodone decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 nefazodone results in decreased expression of CYP2B3 mRNA CTD PMID:24136188 nefazodone multiple interactions EXP 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP2B6 mRNA CTD PMID:32152650 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of CYP2B6 mRNA CTD PMID:32152650 nevirapine multiple interactions EXP 6480464 [Nevirapine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA and [Nevirapine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 nickel atom decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Nickel results in decreased expression of CYP2B10 mRNA CTD PMID:12540486 nickel sulfate decreases expression ISO Cyp2b10 (Mus musculus) 6480464 nickel sulfate results in decreased expression of CYP2B10 mRNA CTD PMID:16100012 nicotine increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Nicotine CTD PMID:12488541 nicotine affects oxidation EXP 6480464 CYP2B6 gene polymorphism affects the oxidation of Nicotine CTD PMID:30906561 nicotine increases oxidation EXP 6480464 CYP2B6 protein results in increased oxidation of Nicotine CTD PMID:30906561 nicotine multiple interactions EXP 6480464 CYP2B6 gene polymorphism affects the reaction [CYP2A6 protein results in increased metabolism of Nicotine] CTD PMID:18004205 Nicotine imine increases chemical synthesis EXP 6480464 CYP2B6 protein results in increased chemical synthesis of nicotine imine CTD PMID:30906561 nifedipine decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Nifedipine results in decreased activity of CYP2B10 protein CTD PMID:18420780 nimesulide decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 nimesulide results in decreased expression of CYP2B3 mRNA CTD PMID:24136188 nimesulide increases glutathionylation EXP 6480464 CYP2B6 protein results in increased glutathionylation of nimesulide CTD PMID:26524229 nitrapyrin increases expression ISO Cyp2b10 (Mus musculus) 6480464 nitrapyrin results in increased expression of CYP2B10 mRNA and nitrapyrin results in increased expression of CYP2B10 protein CTD PMID:29159133 and PMID:35295143 nitrapyrin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 protein affects the reaction [nitrapyrin results in increased expression of CYP2B10 mRNA] CTD PMID:29159133 Nonylphenol increases metabolic processing EXP 6480464 CYP2B6 results in increased metabolism of nonylphenol CTD PMID:9817083 Nonylphenol multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 gene mutant form affects the reaction [nonylphenol results in increased expression of CYP2B10 mRNA] CTD PMID:19041682 Nonylphenol increases expression ISO Cyp2b10 (Mus musculus) 6480464 nonylphenol results in increased expression of CYP2B10 mRNA CTD PMID:19041682 norflurazon multiple interactions EXP 6480464 [CYP1A1 protein co-treated with CYP2B6 protein co-treated with CYP2C19 protein] results in decreased susceptibility to [norflurazone co-treated with metolachlor co-treated with Atrazine] more ... CTD PMID:15853388 and PMID:16608219 Notopterol multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of notopterol] promotes the reaction [Glutathione binds to notopterol] more ... CTD PMID:32198085 Notopterol increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of notopterol CTD PMID:32198085 Notopterol decreases activity EXP 6480464 notopterol results in decreased activity of CYP2B6 protein CTD PMID:32198085 o-anisidine increases oxidation EXP 6480464 CYP2B6 protein results in increased oxidation of 2-anisidine CTD PMID:15828049 O-methyleugenol decreases expression EXP 6480464 methyleugenol results in decreased expression of CYP2B6 mRNA CTD PMID:32234424 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of CYP2B6 mRNA CTD PMID:26505656 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CYP2B6 mRNA CTD PMID:21834667 and PMID:26505656 Octachlorostyrene increases expression ISO Cyp2b10 (Mus musculus) 6480464 octachlorostyrene results in increased expression of CYP2B10 mRNA CTD PMID:19525444 Octachlorostyrene multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 AHR protein inhibits the reaction [octachlorostyrene results in increased expression of CYP2B10 mRNA] CTD PMID:19525444 okadaic acid multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Okadaic Acid inhibits the reaction [Phenobarbital results in increased expression of CYP2B10 mRNA] CTD PMID:27832320 oleanolic acid decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Oleanolic Acid results in decreased expression of CYP2B10 mRNA CTD PMID:23948738 oleic acid multiple interactions EXP 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:24534255 and PMID:30611723 oleic acid decreases expression EXP 6480464 Oleic Acid results in decreased expression of CYP2B6 mRNA CTD PMID:30611723 oltipraz increases expression ISO Cyp2b10 (Mus musculus) 6480464 oltipraz results in increased expression of CYP2B10 mRNA CTD PMID:17627975 oltipraz increases expression EXP 6480464 oltipraz results in increased expression of CYP2B6 mRNA and oltipraz results in increased expression of CYP2B6 protein CTD PMID:19833192 oltipraz decreases activity EXP 6480464 oltipraz results in decreased activity of CYP2B6 protein CTD PMID:19833192 omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP2B6 mRNA CTD PMID:17954527 more ... omeprazole decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Omeprazole results in decreased activity of CYP2B10 protein CTD PMID:18420780 omeprazole affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Omeprazole affects the expression of CYP2B3 mRNA CTD PMID:19483382 omeprazole increases activity EXP 6480464 Omeprazole results in increased activity of CYP2B6 protein CTD PMID:19118567 orphenadrine multiple interactions EXP 6480464 Orphenadrine inhibits the reaction [CYP2B6 protein results in decreased ethylation of 7-ethoxy-4-trifluoromethylcoumarin] and Orphenadrine inhibits the reaction [CYP2B6 protein results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin] CTD PMID:9241656 orphenadrine decreases activity EXP 6480464 Orphenadrine results in decreased activity of CYP2B6 protein CTD PMID:12464242 more ... ortho-Aminoazotoluene multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 gene mutant form inhibits the reaction [o-Aminoazotoluene results in increased expression of CYP2B10 mRNA] and NR1I3 gene mutant form inhibits the reaction [o-Aminoazotoluene results in increased expression of CYP2B10 protein] CTD PMID:21672546 ortho-Aminoazotoluene increases expression ISO Cyp2b10 (Mus musculus) 6480464 o-Aminoazotoluene results in increased expression of CYP2B10 mRNA and o-Aminoazotoluene results in increased expression of CYP2B10 protein CTD PMID:21672546 Oxadiazon multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 mutant form inhibits the reaction [oxadiazon results in increased expression of CYP2B10 mRNA] CTD PMID:26710982 Oxadiazon increases expression ISO Cyp2b10 (Mus musculus) 6480464 oxadiazon results in increased expression of CYP2B10 mRNA CTD PMID:26710982 oxazepam increases expression ISO Cyp2b10 (Mus musculus) 6480464 Oxazepam results in increased expression of CYP2B10 mRNA and Oxazepam results in increased expression of CYP2B10 protein CTD PMID:12727805 more ... oxolane increases activity ISO Cyp2b10 (Mus musculus) 6480464 tetrahydrofuran results in increased activity of CYP2B10 protein CTD PMID:28495613 oxolane increases expression ISO Cyp2b10 (Mus musculus) 6480464 tetrahydrofuran results in increased expression of CYP2B10 mRNA CTD PMID:28495613 oxolane multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I2 protein affects the reaction [tetrahydrofuran results in increased expression of CYP2B10 mRNA] and NR1I3 protein affects the reaction [tetrahydrofuran results in increased expression of CYP2B10 mRNA] CTD PMID:28495613 oxybenzone decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 oxybenzone results in decreased expression of CYP2B3 mRNA CTD PMID:30316929 Oxyfluorfen increases expression ISO Cyp2b10 (Mus musculus) 6480464 oxyfluorofen results in increased expression of CYP2B10 mRNA CTD PMID:22539621 ozone increases expression ISO Cyp2b10 (Mus musculus) 6480464 Ozone results in increased expression of CYP2B10 mRNA and Ozone results in increased expression of CYP2B6 mRNA CTD PMID:24336422 and PMID:33026818 p-menthan-3-ol increases expression ISO Cyp2b10 (Mus musculus) 6480464 Menthol results in increased expression of CYP2B10 mRNA CTD PMID:24594507 p-menthan-3-ol multiple interactions EXP 6480464 Menthol inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CYP2B6 mRNA CTD PMID:29067470 paracetamol multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2B6 mRNA CTD PMID:33819548 paraquat increases expression EXP 6480464 Paraquat results in increased expression of CYP2B6 mRNA CTD PMID:34681664 parathion affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of Parathion CTD PMID:15557345 and PMID:17079358 parathion increases expression EXP 6480464 Parathion results in increased expression of CYP2B6 mRNA CTD PMID:26196221 parathion decreases sulfation EXP 6480464 CYP2B6 protein results in decreased sulfation of Parathion CTD PMID:17079358 Pargyline decreases activity EXP 6480464 Pargyline results in decreased activity of CYP2B6 protein CTD PMID:25656918 Pargyline multiple interactions EXP 6480464 Pargyline inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:25656918 paricalcitol multiple interactions EXP 6480464 [Phosphorus co-treated with paricalcitol] results in decreased expression of CYP2B6 mRNA CTD PMID:17715259 paroxetine decreases activity EXP 6480464 Paroxetine results in decreased activity of CYP2B6 protein CTD PMID:21915887 paroxetine multiple interactions EXP 6480464 Paroxetine inhibits the reaction [CYP2B6 protein results in increased chemical synthesis of hydroxybupropion] and Paroxetine inhibits the reaction [CYP2B6 protein results in increased metabolism of Bupropion] CTD PMID:21915887 pazopanib increases expression EXP 6480464 pazopanib results in increased expression of CYP2B6 mRNA CTD PMID:29356861 pencycuron affects binding EXP 6480464 pencycuron binds to CYP2B6 protein CTD PMID:32278787 pendimethalin multiple interactions EXP 6480464 CYP2B6 protein results in increased metabolism of and results in decreased susceptibility to pendimethalin CTD PMID:15853388 pentachlorophenol increases expression EXP 6480464 Pentachlorophenol results in increased expression of CYP2B6 protein CTD PMID:15548381 perflubutane increases expression EXP 6480464 perfluorobutane results in increased expression of CYP2B6 mRNA CTD PMID:23567314 perfluorobutanesulfonic acid increases expression ISO Cyp2b10 (Mus musculus) 6480464 perfluorobutanesulfonic acid results in increased expression of CYP2B10 mRNA CTD PMID:32534104 perfluorobutanesulfonic acid increases expression EXP 6480464 perfluorobutanesulfonic acid results in increased expression of CYP2B6 mRNA CTD PMID:35337807 perfluorodecanoic acid multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 protein affects the reaction [perfluorodecanoic acid results in increased expression of CYP2B10 mRNA] CTD PMID:18648086 perfluorodecanoic acid increases expression ISO Cyp2b10 (Mus musculus) 6480464 perfluorodecanoic acid results in increased expression of CYP2B10 mRNA CTD PMID:18648086 and PMID:27344344 perfluorodecanoic acid increases expression EXP 6480464 perfluorodecanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 and PMID:35337807 perfluorododecanoic acid decreases expression ISO Cyp2b10 (Mus musculus) 6480464 perfluorododecanoic acid results in decreased expression of CYP2B10 mRNA CTD PMID:23567314 perfluoroheptanoic acid decreases expression ISO Cyp2b10 (Mus musculus) 6480464 perfluoro-n-heptanoic acid results in decreased expression of CYP2B10 mRNA CTD PMID:23567314 perfluoroheptanoic acid increases expression EXP 6480464 perfluoro-n-heptanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 and PMID:35337807 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 and PMID:35337807 perfluorohexanesulfonic acid increases expression ISO Cyp2b10 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of CYP2B10 mRNA CTD PMID:28558994 perfluorohexanoic acid increases expression EXP 6480464 perfluorohexanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 and PMID:35337807 perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 perfluorononanoic acid multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in increased expression of CYP2B10 mRNA and [PPARA gene mutant form results in increased susceptibility to perfluoro-n-nonanoic acid] which results in increased expression of CYP2B10 mRNA CTD PMID:25949234 and PMID:33483757 perfluorononanoic acid increases expression ISO Cyp2b10 (Mus musculus) 6480464 perfluoro-n-nonanoic acid results in increased expression of CYP2B10 mRNA CTD PMID:25543169 and PMID:28558994 perfluorooctane-1-sulfonic acid increases expression ISO Cyp2b10 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of CYP2B10 mRNA CTD PMID:19429403 more ... perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CYP2B6 mRNA CTD PMID:21723365 more ... perfluorooctane-1-sulfonic acid decreases expression ISO Cyp2b10 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP2B10 mRNA CTD PMID:23567314 perfluorooctane-1-sulfonic acid multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of CYP2B10 mRNA more ... CTD PMID:20936131 more ... perfluorooctane-1-sulfonic acid affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 perfluorooctane sulfonic acid affects the expression of CYP2B3 mRNA CTD PMID:17383973 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 perfluorooctane sulfonic acid inhibits the reaction [CYP2B6 protein results in increased oxidation of 7-ethoxy-4-trifluoromethylcoumarin] CTD PMID:21964418 perfluorooctanoic acid increases expression ISO Cyp2b10 (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of CYP2B10 mRNA and perfluorooctanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:17681415 more ... perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:23567314 more ... perfluorooctanoic acid decreases expression ISO Cyp2b10 (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of CYP2B10 mRNA CTD PMID:22154759 and PMID:23567314 perfluorooctanoic acid affects expression ISO Cyp2b10 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of CYP2B10 mRNA CTD PMID:18281256 perfluorooctanoic acid decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in decreased expression of CYP2B3 mRNA CTD PMID:19162173 perfluorooctanoic acid affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 perfluorooctanoic acid affects the expression of CYP2B3 mRNA CTD PMID:17383973 perfluorooctanoic acid multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [perfluorooctanoic acid co-treated with Dietary Fats more ... CTD PMID:18467677 more ... perfluoroundecanoic acid decreases expression ISO Cyp2b10 (Mus musculus) 6480464 perfluoroundecanoic acid results in decreased expression of CYP2B10 mRNA CTD PMID:23567314 perillyl aldehyde multiple interactions EXP 6480464 perillaldehyde inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] CTD PMID:18611395 permethrin increases expression EXP 6480464 Permethrin results in increased expression of CYP2B6 mRNA CTD PMID:19326768 permethrin increases expression ISO Cyp2b10 (Mus musculus) 6480464 Permethrin results in increased expression of CYP2B10 mRNA CTD PMID:30629241 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 permethrin affects activity EXP 6480464 Permethrin affects the activity of CYP2B6 protein CTD PMID:21924250 phenanthrene increases expression EXP 6480464 phenanthrene results in increased expression of CYP2B6 mRNA CTD PMID:31181217 phenanthrene increases expression ISO Cyp2b10 (Mus musculus) 6480464 phenanthrene results in increased expression of CYP2B10 mRNA and phenanthrene results in increased expression of CYP2B10 protein CTD PMID:31181217 phenanthrene multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 mRNA] and NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 protein] CTD PMID:31181217 phencyclidine affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of Phencyclidine analog CTD PMID:16782764 phencyclidine decreases activity EXP 6480464 Phencyclidine analog results in decreased activity of CYP2B6 protein and Phencyclidine results in decreased activity of CYP2B6 protein CTD PMID:16782764 phencyclidine affects oxidation EXP 6480464 CYP2B6 protein affects the oxidation of Phencyclidine CTD PMID:16782764 Phenelzine decreases activity EXP 6480464 Phenelzine results in decreased activity of CYP2B6 protein CTD PMID:25656918 Phenelzine multiple interactions EXP 6480464 Phenelzine inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:25656918 phenobarbital increases expression ISO Cyp2b10 (Mus musculus) 6480464 Phenobarbital results in increased expression of CYP2B10 mRNA more ... CTD PMID:10064569 more ... phenobarbital multiple interactions ISO Cyp2b3 (Rattus norvegicus) 6480464 Phenobarbital promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA] CTD PMID:22815988 phenobarbital increases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of CYP2B10 mRNA CTD PMID:24449422 phenobarbital affects localization EXP 6480464 Phenobarbital affects the localization of CYP2B6 protein CTD PMID:24878338 phenobarbital increases activity EXP 6480464 Phenobarbital results in increased activity of CYP2B6 protein CTD PMID:14977870 more ... phenobarbital affects expression ISO Cyp2b10 (Mus musculus) 6480464 Phenobarbital affects the expression of CYP2B10 mRNA CTD PMID:9007836 phenobarbital increases activity ISO Cyp2b10 (Mus musculus) 6480464 Phenobarbital results in increased activity of CYP2B10 protein CTD PMID:16542693 and PMID:20403969 phenobarbital decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Phenobarbital results in decreased expression of CYP2B3 mRNA CTD PMID:11328961 and PMID:19162173 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP2B10 mRNA more ... CTD PMID:12571232 more ... phenobarbital multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA more ... CTD PMID:12049174 more ... phenobarbital multiple interactions EXP 6480464 [Celsior co-treated with Phenobarbital] results in increased expression of CYP2B6 mRNA more ... CTD PMID:10037683 more ... phenthoate decreases activity EXP 6480464 phenthoate results in decreased activity of CYP2B6 protein CTD PMID:22310298 phenthoate increases expression EXP 6480464 phenthoate results in increased expression of CYP2B6 mRNA CTD PMID:22310298 phenytoin multiple interactions EXP 6480464 [Phenytoin results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA more ... CTD PMID:12695351 more ... phenytoin decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Phenytoin results in decreased expression of CYP2B10 protein CTD PMID:19226368 phenytoin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP2B10 mRNA CTD PMID:21224054 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of CYP2B6 mRNA and Phenytoin results in increased expression of CYP2B6 protein CTD PMID:12571232 more ... phenytoin increases activity EXP 6480464 Phenytoin results in increased activity of CYP2B6 protein CTD PMID:14977870 phlorizin decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Phlorhizin results in decreased expression of CYP2B6 mRNA CTD PMID:22538082 phorone increases expression ISO Cyp2b10 (Mus musculus) 6480464 phorone results in increased expression of CYP2B10 mRNA CTD PMID:24494203 phorone multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NFE2L2 gene mutant form inhibits the reaction [phorone results in increased expression of CYP2B10 mRNA] CTD PMID:24494203 phosphorus atom multiple interactions EXP 6480464 [Phosphorus co-treated with paricalcitol] results in decreased expression of CYP2B6 mRNA CTD PMID:17715259 phosphorus(.) multiple interactions EXP 6480464 [Phosphorus co-treated with paricalcitol] results in decreased expression of CYP2B6 mRNA CTD PMID:17715259 physcion increases hydroxylation EXP 6480464 CYP2B6 protein results in increased hydroxylation of physcione CTD PMID:29667811 piclamilast increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of piclamilast CTD PMID:12464242 pimecrolimus increases expression EXP 6480464 pimecrolimus results in increased expression of CYP2B6 mRNA CTD PMID:29356861 pioglitazone increases expression EXP 6480464 pioglitazone results in increased expression of CYP2B6 protein CTD PMID:12642470 pioglitazone increases expression ISO Cyp2b10 (Mus musculus) 6480464 Pioglitazone results in increased expression of CYP2B10 mRNA CTD PMID:28541575 piperonyl butoxide multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of CYP2B10 mRNA CTD PMID:19690152 and PMID:20101389 piperonyl butoxide increases expression ISO Cyp2b10 (Mus musculus) 6480464 Piperonyl Butoxide results in increased expression of CYP2B10 mRNA CTD PMID:17014948 more ... pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP2B6 mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CYP2B6 mRNA CTD PMID:27551952 pirinixic acid decreases expression ISO Cyp2b10 (Mus musculus) 6480464 pirinixic acid results in decreased expression of CYP2B10 mRNA CTD PMID:19850644 more ... pirinixic acid increases expression ISO Cyp2b10 (Mus musculus) 6480464 pirinixic acid results in increased expression of CYP2B10 mRNA and pirinixic acid results in increased expression of CYP2B10 protein CTD PMID:11798191 more ... pirinixic acid multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYP2B10 mRNA more ... CTD PMID:17962186 more ... pirinixic acid affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 pirinixic acid affects the expression of CYP2B3 mRNA CTD PMID:19483382 PK-11195 increases expression EXP 6480464 PK 11195 results in increased expression of CYP2B6 mRNA CTD PMID:21315811 pravastatin affects expression ISO Cyp2b10 (Mus musculus) 6480464 Pravastatin affects the expression of CYP2B10 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [1 more ... CTD PMID:19433268 more ... pregnenolone 16alpha-carbonitrile affects expression ISO Cyp2b10 (Mus musculus) 6480464 Pregnenolone Carbonitrile affects the expression of CYP2B10 mRNA CTD PMID:31388680 pregnenolone 16alpha-carbonitrile increases expression ISO Cyp2b10 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of CYP2B10 mRNA and Pregnenolone Carbonitrile results in increased expression of CYP2B10 protein CTD PMID:15986414 more ... pregnenolone 16alpha-carbonitrile increases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in increased expression of CYP2B3 mRNA CTD PMID:15596064 pregnenolone 16alpha-carbonitrile decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP2B3 mRNA CTD PMID:19162173 primaquine increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Primaquine CTD PMID:19616568 primaquine multiple interactions EXP 6480464 [CYP2B6 protein results in increased expression of HBG2 protein] which affects the susceptibility to Primaquine CTD PMID:19616568 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of CYP2B6 mRNA and prochloraz results in increased expression of CYP2B6 protein CTD PMID:28058446 and PMID:33150952 prochloraz increases expression ISO Cyp2b10 (Mus musculus) 6480464 prochloraz results in increased expression of CYP2B10 mRNA and prochloraz results in increased expression of CYP2B10 protein CTD PMID:28058446 and PMID:33150952 prochloraz multiple interactions EXP 6480464 [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [prochloraz results in increased expression of CYP2B10 protein] CTD PMID:28058446 profenofos increases expression EXP 6480464 profenofos results in increased expression of CYP2B6 mRNA CTD PMID:22310298 profenofos increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of profenofos CTD PMID:23415833 profenofos multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol CTD PMID:23415833 profenofos decreases activity EXP 6480464 profenofos results in decreased activity of CYP2B6 protein CTD PMID:22310298 progesterone decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Progesterone results in decreased expression of CYP2B10 mRNA CTD PMID:11075820 progesterone increases expression EXP 6480464 Progesterone results in increased expression of CYP2B6 mRNA CTD PMID:22837389 progesterone multiple interactions EXP 6480464 [Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:21768169 progesterone increases expression ISO Cyp2b10 (Mus musculus) 6480464 Progesterone results in increased expression of CYP2B10 mRNA CTD PMID:7771797 propiconazole multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1H3 gene mutant form inhibits the reaction [propiconazole results in increased expression of CYP2B10 mRNA] CTD PMID:25949234 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP2B6 mRNA CTD PMID:30293151 and PMID:33575850 propiconazole multiple interactions EXP 6480464 [propiconazole co-treated with fludioxonil] results in increased expression of CYP2B6 mRNA CTD PMID:33575850 propiconazole affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 propiconazole affects the expression of CYP2B3 mRNA CTD PMID:17383973 propiconazole increases expression ISO Cyp2b10 (Mus musculus) 6480464 propiconazole results in increased expression of CYP2B10 mRNA CTD PMID:15603923 more ... propofol increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Propofol CTD PMID:15769884 propyzamide increases expression ISO Cyp2b10 (Mus musculus) 6480464 pronamide results in increased expression of CYP2B10 mRNA and pronamide results in increased expression of CYP2B10 protein CTD PMID:25092647 pterostilbene increases expression EXP 6480464 pterostilbene results in increased expression of CYP2B6 mRNA CTD PMID:30394306 pyrene multiple interactions EXP 6480464 [fluoranthene co-treated with Benzo(a)pyrene] inhibits the reaction [pyrene results in increased expression of CYP2B6 mRNA] more ... CTD PMID:26160115 and PMID:33249052 pyrene multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 gene mutant form inhibits the reaction [pyrene results in increased expression of CYP2B10 mRNA] CTD PMID:26160115 pyrene increases expression EXP 6480464 pyrene results in increased expression of CYP2B6 mRNA CTD PMID:26160115 and PMID:33249052 pyrene increases expression ISO Cyp2b10 (Mus musculus) 6480464 pyrene results in increased expression of CYP2B10 mRNA CTD PMID:17618724 and PMID:26160115 pyrethrins increases expression EXP 6480464 Pyrethrins results in increased expression of CYP2B6 mRNA CTD PMID:18022748 quercetin decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Quercetin results in decreased activity of CYP2B10 protein CTD PMID:18420780 quercetin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Dietary Fats co-treated with Quercetin] affects the expression of CYP2B10 mRNA CTD PMID:25047408 quercetin affects expression ISO Cyp2b10 (Mus musculus) 6480464 Quercetin affects the expression of CYP2B10 mRNA CTD PMID:16455785 quinidine decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Quinidine results in decreased activity of CYP2B10 protein CTD PMID:18420780 reserpine multiple interactions EXP 6480464 [Reserpine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 resveratrol decreases activity ISO Cyp2b10 (Mus musculus) 6480464 resveratrol results in decreased activity of CYP2B10 protein CTD PMID:18420780 retinyl acetate multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [bisphenol A co-treated with retinol acetate] results in increased expression of CYP2B10 mRNA CTD PMID:28123100 retinyl acetate decreases expression ISO Cyp2b10 (Mus musculus) 6480464 retinol acetate results in decreased expression of CYP2B10 mRNA CTD PMID:28123100 rifampicin increases expression EXP 6480464 Rifampin results in increased expression of CYP2B6 mRNA and Rifampin results in increased expression of CYP2B6 protein CTD PMID:12040753 more ... rifampicin increases expression ISO Cyp2b10 (Mus musculus) 6480464 Rifampin results in increased expression of CYP2B10 mRNA CTD PMID:30503582 rifampicin increases activity EXP 6480464 Rifampin results in increased activity of CYP2B6 protein CTD PMID:14977870 more ... rifampicin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in increased expression of CYP2B10 protein and [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP2B10 mRNA CTD PMID:21224054 and PMID:25835148 rifampicin multiple interactions EXP 6480464 [Rifampin co-treated with Monocrotophos] results in increased activity of CYP2B6 protein more ... CTD PMID:12695351 more ... ritonavir increases activity EXP 6480464 Ritonavir results in increased activity of CYP2B6 protein CTD PMID:26626330 ritonavir increases expression EXP 6480464 Ritonavir results in increased expression of CYP2B6 protein CTD PMID:14977870 romidepsin affects metabolic processing EXP 6480464 CYP2B6 protein affects the metabolism of romidepsin CTD PMID:15635176 selenium atom increases expression ISO Cyp2b10 (Mus musculus) 6480464 Selenium deficiency results in increased expression of CYP2B10 mRNA CTD PMID:16170372 senecionine increases expression EXP 6480464 senecionine results in increased expression of CYP2B6 mRNA CTD PMID:26100227 senecionine affects expression ISO Cyp2b10 (Mus musculus) 6480464 senecionine affects the expression of CYP2B10 mRNA CTD PMID:31606820 sertraline multiple interactions EXP 6480464 [Sertraline results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion and CYP2B6 protein results in decreased methylation of and results in increased metabolism of Sertraline CTD PMID:15547048 and PMID:26599973 sertraline decreases activity EXP 6480464 Sertraline results in decreased activity of CYP2B6 protein CTD PMID:26599973 Shikonin decreases activity EXP 6480464 shikonin results in decreased activity of CYP2B6 protein CTD PMID:28941798 sibutramine decreases activity EXP 6480464 sibutramine results in decreased activity of CYP2B6 protein CTD PMID:23777987 sibutramine multiple interactions EXP 6480464 sibutramine inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:23777987 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of CYP2B6 mRNA CTD PMID:15802384 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of CYP2B6 mRNA CTD PMID:25929522 sodium arsenite affects methylation EXP 6480464 sodium arsenite affects the methylation of CYP2B6 gene CTD PMID:28589171 sodium arsenite multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP2B10 mRNA CTD PMID:32045263 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CYP2B6 mRNA CTD PMID:29301061 sodium dichromate affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 sodium bichromate affects the expression of CYP2B3 mRNA CTD PMID:22110744 sodium dichromate decreases expression ISO Cyp2b10 (Mus musculus) 6480464 sodium bichromate results in decreased expression of CYP2B10 mRNA CTD PMID:22155349 steviol increases expression EXP 6480464 steviol results in increased expression of CYP2B6 mRNA CTD PMID:28887089 streptozocin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Berberine inhibits the reaction [Streptozocin results in increased expression of CYP2B10 mRNA] and Streptozocin promotes the reaction [Dietary Fats results in decreased expression of CYP2B10 mRNA] CTD PMID:22342832 and PMID:29382564 streptozocin increases expression ISO Cyp2b10 (Mus musculus) 6480464 Streptozocin results in increased expression of CYP2B10 mRNA CTD PMID:22342832 succimer multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CYP2B10 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2B10 mRNA CTD PMID:21641980 and PMID:26378955 Sudan I increases oxidation EXP 6480464 CYP2B6 protein results in increased oxidation of 1-phenylazo-2-naphthol CTD PMID:17159775 Sudan I multiple interactions EXP 6480464 CYB5A protein inhibits the reaction [CYP2B6 protein results in increased oxidation of 1-phenylazo-2-naphthol] CTD PMID:17159775 sulconazole increases expression EXP 6480464 sulconazole results in increased expression of CYP2B6 mRNA CTD PMID:31312845 sulconazole multiple interactions EXP 6480464 [sulconazole co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA and [sulconazole co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 sulfasalazine increases expression ISO Cyp2b10 (Mus musculus) 6480464 Sulfasalazine results in increased expression of CYP2B10 mRNA CTD PMID:31830553 sulfinpyrazone increases expression EXP 6480464 Sulfinpyrazone results in increased expression of CYP2B6 protein CTD PMID:14977870 sulfluramid increases expression EXP 6480464 sulfluramid results in increased expression of CYP2B6 mRNA CTD PMID:35337807 sulfoxaflor multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I2 gene mutant form inhibits the reaction [sulfoxaflor results in increased expression of CYP2B10 mRNA] and NR1I3 gene mutant form inhibits the reaction [sulfoxaflor results in increased expression of CYP2B10 mRNA] CTD PMID:23607986 sulfoxaflor increases expression ISO Cyp2b10 (Mus musculus) 6480464 sulfoxaflor results in increased expression of CYP2B10 mRNA CTD PMID:23607986 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of CYP2B6 protein CTD PMID:19812351 tamoxifen multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Tamoxifen] affects the expression of CYP2B10 mRNA CTD PMID:29974145 tamoxifen increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Tamoxifen CTD PMID:29285606 tamoxifen multiple interactions EXP 6480464 [CYP2B6 protein results in increased metabolism of Tamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 tamoxifen increases activity EXP 6480464 Tamoxifen metabolite results in increased activity of CYP2B6 protein CTD PMID:29285606 tamoxifen decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Tamoxifen results in decreased activity of CYP2B10 protein CTD PMID:18420780 tamoxifen increases expression ISO Cyp2b10 (Mus musculus) 6480464 Tamoxifen results in increased expression of CYP2B10 mRNA CTD PMID:7771797 tamoxifen affects expression ISO Cyp2b10 (Mus musculus) 6480464 Tamoxifen affects the expression of CYP2B10 mRNA CTD PMID:20937368 tartrazine multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2B6 mRNA CTD PMID:33819548 tauroursodeoxycholic acid decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 ursodoxicoltaurine results in decreased expression of CYP2B3 mRNA CTD PMID:15885361 tebuconazole multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 inhibits the reaction [tebuconazole results in increased expression of CYP2B10 mRNA] CTD PMID:25656644 tebuconazole increases expression EXP 6480464 tebuconazole results in increased expression of CYP2B6 mRNA CTD PMID:30458266 and PMID:33575850 tebuconazole multiple interactions EXP 6480464 [tebuconazole co-treated with fludioxonil] results in increased expression of CYP2B6 mRNA CTD PMID:33575850 tebuconazole increases expression ISO Cyp2b10 (Mus musculus) 6480464 tebuconazole results in increased expression of CYP2B10 mRNA CTD PMID:25656644 tebufenozide increases expression EXP 6480464 tebufenozide results in increased expression of CYP2B6 mRNA CTD PMID:22310298 teriflunomide increases expression EXP 6480464 teriflunomide results in increased expression of CYP2B6 mRNA CTD PMID:30364229 teriflunomide increases activity EXP 6480464 teriflunomide results in increased activity of CYP2B6 protein CTD PMID:30364229 tert-butanol increases expression ISO Cyp2b10 (Mus musculus) 6480464 tert-Butyl Alcohol results in increased expression of CYP2B10 mRNA CTD PMID:19760798 testosterone increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Testosterone CTD PMID:12464242 testosterone multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Testosterone metabolite inhibits the reaction [1 more ... CTD PMID:24769335 testosterone affects expression ISO Cyp2b10 (Mus musculus) 6480464 Testosterone affects the expression of CYP2B10 mRNA CTD PMID:7771797 testosterone decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Testosterone results in decreased activity of CYP2B10 protein CTD PMID:18420780 testosterone decreases expression ISO Cyp2b10 (Mus musculus) 6480464 Testosterone results in decreased expression of CYP2B10 mRNA CTD PMID:11075820 and PMID:21669218 testosterone increases hydroxylation EXP 6480464 CYP2B6 protein results in increased hydroxylation of Testosterone CTD PMID:19833192 tetrachloroethene increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Tetrachloroethylene CTD PMID:11684365 tetrachloromethane affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Carbon Tetrachloride affects the expression of CYP2B3 mRNA CTD PMID:12734012 tetrachloromethane multiple interactions ISO Cyp2b3 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP2B3 mRNA] CTD PMID:31150632 tetrachloromethane increases expression ISO Cyp2b10 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CYP2B10 mRNA CTD PMID:16273607 more ... tetrachloromethane multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Tamoxifen] affects the expression of CYP2B10 mRNA more ... CTD PMID:16273607 more ... tetrachloromethane decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of CYP2B3 mRNA and Carbon Tetrachloride results in decreased expression of CYP2B3 protein CTD PMID:17606319 and PMID:31150632 tetrahydrocurcumin decreases expression ISO Cyp2b10 (Mus musculus) 6480464 tetrahydrocurcumin results in decreased expression of CYP2B10 mRNA CTD PMID:26102010 thalidomide increases expression EXP 6480464 Thalidomide results in increased expression of CYP2B6 mRNA CTD PMID:24460184 and PMID:28496040 Theaflavin 3,3'-digallate affects expression EXP 6480464 theaflavin-3 and 3'-digallate affects the expression of CYP2B6 mRNA CTD PMID:34925699 thiabendazole increases expression EXP 6480464 Thiabendazole results in increased expression of CYP2B6 mRNA CTD PMID:18570159 thiacloprid multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B10 mRNA and [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CYP2B10 mRNA CTD PMID:32736067 and PMID:32745781 thiacloprid multiple interactions EXP 6480464 [clothianidin co-treated with thiacloprid] results in increased expression of CYP2B6 protein more ... CTD PMID:32201337 thiacloprid increases expression EXP 6480464 thiacloprid results in increased expression of CYP2B6 mRNA CTD PMID:32201337 thioacetamide affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Thioacetamide affects the expression of CYP2B3 mRNA CTD PMID:19483382 thioacetamide decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of CYP2B3 mRNA CTD PMID:34492290 thiophanate-methyl multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B10 mRNA and [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CYP2B10 mRNA CTD PMID:32736067 and PMID:32745781 Thiotepa affects response to substance EXP 6480464 CYP2B6 protein affects the susceptibility to Thiotepa CTD PMID:19076156 Thiotepa affects export EXP 6480464 CYP2B6 gene SNP affects the export of Thiotepa CTD PMID:19076156 Thiotepa decreases activity EXP 6480464 Thiotepa results in decreased activity of CYP2B6 protein CTD PMID:15769884 Thiotepa multiple interactions EXP 6480464 Thiotepa inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] and Thiotepa inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion] CTD PMID:18611395 and PMID:23777987 ticlopidine multiple interactions EXP 6480464 Ticlopidine binds to and results in decreased activity of CYP2B6 protein more ... CTD PMID:16855053 more ... ticlopidine decreases activity EXP 6480464 Ticlopidine results in decreased activity of CYP2B6 protein CTD PMID:19328226 more ... tienilic acid multiple interactions EXP 6480464 Ticrynafen inhibits the reaction [CYP2B6 protein results in increased chemical synthesis of hydroxybupropion] and Ticrynafen inhibits the reaction [CYP2B6 protein results in increased metabolism of Bupropion] CTD PMID:21915887 tienilic acid decreases activity EXP 6480464 Ticrynafen results in decreased activity of CYP2B6 protein CTD PMID:21915887 tirapazamine multiple interactions EXP 6480464 POR protein promotes the reaction [CYP2B6 protein results in increased susceptibility to tirapazamine] CTD PMID:10919648 titanium dioxide decreases expression ISO Cyp2b10 (Mus musculus) 6480464 titanium dioxide results in decreased expression of CYP2B10 mRNA CTD PMID:23131501 and PMID:23557971 titanium dioxide multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP2B10 mRNA CTD PMID:29950665 toxaphene multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 gene mutant form inhibits the reaction [Toxaphene results in increased expression of CYP2B10 mRNA] CTD PMID:26187448 and PMID:28218408 toxaphene increases expression ISO Cyp2b10 (Mus musculus) 6480464 Toxaphene results in increased expression of CYP2B10 mRNA CTD PMID:26187448 and PMID:28218408 tranylcypromine multiple interactions EXP 6480464 Tranylcypromine inhibits the reaction [[CYP2B6 protein results in increased metabolism of 7-ethoxy-4-trifluoromethylcoumarin] which results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin] and Tranylcypromine inhibits the reaction [CYP2B6 protein results in increased metabolism of Bupropion] CTD PMID:23850985 and PMID:28119166 tranylcypromine decreases activity EXP 6480464 Tranylcypromine results in decreased activity of CYP2B6 protein CTD PMID:23850985 and PMID:28119166 tremolite asbestos decreases expression ISO Cyp2b10 (Mus musculus) 6480464 tremolite results in decreased expression of CYP2B10 mRNA CTD PMID:29279043 triadimefon multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1H3 gene mutant form inhibits the reaction [triadimefon results in increased expression of CYP2B10 mRNA] CTD PMID:25949234 triadimefon affects expression ISO Cyp2b3 (Rattus norvegicus) 6480464 triadimefon affects the expression of CYP2B3 mRNA CTD PMID:17383973 triadimefon increases expression ISO Cyp2b10 (Mus musculus) 6480464 triadimefon results in increased expression of CYP2B10 mRNA CTD PMID:19010342 more ... trichloroethene increases expression ISO Cyp2b10 (Mus musculus) 6480464 Trichloroethylene results in increased expression of CYP2B10 mRNA CTD PMID:19448997 and PMID:25549359 triclocarban increases expression EXP 6480464 triclocarban results in increased expression of CYP2B6 mRNA CTD PMID:22761658 triclocarban increases expression ISO Cyp2b10 (Mus musculus) 6480464 triclocarban results in increased expression of CYP2B10 mRNA and triclocarban results in increased expression of CYP2B10 protein CTD PMID:22761658 triclocarban multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 NR1I3 gene mutant form inhibits the reaction [triclocarban results in increased expression of CYP2B10 mRNA] and NR1I3 gene mutant form inhibits the reaction [triclocarban results in increased expression of CYP2B10 protein] CTD PMID:22761658 triclocarban multiple interactions EXP 6480464 ESR1 protein affects the reaction [triclocarban results in increased expression of CYP2B6 mRNA] CTD PMID:22761658 triclosan increases expression EXP 6480464 Triclosan results in increased expression of CYP2B6 mRNA CTD PMID:29849464 triclosan affects expression EXP 6480464 Triclosan affects the expression of CYP2B6 mRNA CTD PMID:34681664 triclosan multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of CYP2B6 mRNA CTD PMID:33819548 triflumuron increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of triflumuron CTD PMID:31082524 trifluralin multiple interactions EXP 6480464 CYP2B6 protein results in increased metabolism of and results in decreased susceptibility to Trifluralin CTD PMID:15853388 triphenyl phosphate multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [tris(1 more ... CTD PMID:29112739 and PMID:32360330 Triptolide multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 TRAJ18 protein affects the reaction [triptolide results in decreased expression of CYP2B10 mRNA] CTD PMID:32987112 Triptolide decreases expression ISO Cyp2b10 (Mus musculus) 6480464 triptolide results in decreased expression of CYP2B10 mRNA CTD PMID:32835833 and PMID:32987112 triptonide increases expression ISO Cyp2b10 (Mus musculus) 6480464 triptonide results in increased expression of CYP2B10 mRNA CTD PMID:33045310 Tris(1-aziridinyl)phosphine oxide affects export EXP 6480464 CYP2B6 gene SNP affects the export of Triethylenephosphoramide CTD PMID:19076156 Tris(1-aziridinyl)phosphine oxide affects response to substance EXP 6480464 CYP2B6 protein affects the susceptibility to Triethylenephosphoramide CTD PMID:19076156 troglitazone multiple interactions EXP 6480464 [Oleic Acid co-treated with troglitazone] results in increased expression of CYP2B6 mRNA and [troglitazone results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 and PMID:24534255 troglitazone increases expression EXP 6480464 Troglitazone results in increased expression of CYP2B6 mRNA and Troglitazone results in increased expression of CYP2B6 protein CTD PMID:10752642 more ... troglitazone increases expression ISO Cyp2b10 (Mus musculus) 6480464 troglitazone results in increased expression of CYP2B6 mRNA CTD PMID:28973697 tryptamines decreases activity EXP 6480464 Tryptamines analog results in decreased activity of CYP2B6 protein CTD PMID:26599973 tryptamines multiple interactions EXP 6480464 [Tryptamines analog results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion CTD PMID:26599973 ursodeoxycholic acid affects expression ISO Cyp2b10 (Mus musculus) 6480464 Ursodeoxycholic Acid affects the expression of CYP2B10 protein CTD PMID:16472600 ursodeoxycholic acid multiple interactions ISO Cyp2b3 (Rattus norvegicus) 6480464 Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA] and Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 protein] CTD PMID:32198087 ursodeoxycholic acid decreases expression ISO Cyp2b3 (Rattus norvegicus) 6480464 Ursodeoxycholic Acid results in decreased expression of CYP2B3 mRNA CTD PMID:15885361 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CYP2B6 mRNA CTD PMID:29154799 and PMID:29501571 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of CYP2B6 gene CTD PMID:29501571 valproic acid increases response to substance EXP 6480464 CYP2B6 protein results in increased susceptibility to Valproic Acid CTD PMID:28762043 valproic acid increases metabolic processing EXP 6480464 CYP2B6 protein results in increased metabolism of Valproic Acid CTD PMID:16945988 valproic acid increases expression ISO Cyp2b10 (Mus musculus) 6480464 Valproic Acid results in increased expression of CYP2B10 mRNA CTD PMID:24535564 valproic acid affects expression ISO Cyp2b10 (Mus musculus) 6480464 Valproic Acid affects the expression of CYP2B10 mRNA CTD PMID:17963808 vatalanib multiple interactions EXP 6480464 [vatalanib co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mRNA CTD PMID:31312845 verapamil decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Verapamil results in decreased activity of CYP2B10 protein CTD PMID:18420780 verteporfin multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 Verteporfin inhibits the reaction [1 more ... CTD PMID:29893953 warfarin decreases activity ISO Cyp2b10 (Mus musculus) 6480464 Warfarin results in decreased activity of CYP2B10 protein CTD PMID:18420780 zaragozic acid A increases expression ISO Cyp2b10 (Mus musculus) 6480464 squalestatin 1 results in increased expression of CYP2B10 mRNA CTD PMID:27225895 zinc atom multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA CTD PMID:33549593 zinc(0) multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA CTD PMID:33549593 ziram multiple interactions ISO Cyp2b10 (Mus musculus) 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B10 mRNA and [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CYP2B10 mRNA CTD PMID:32736067 and PMID:32745781
